




HORHONA.L REGULAT IO N OF GLYCINE CL EA.VA.GE E NZYME SYS T EM
by
Gehan M.Y. Mabrouk , B.V .S e:.
A t he sis s ubmi tted t o the
Se:hool of Gr aduate St ud ies
in pa rtia l f ul f ilme n t of the
r e qu i relllents for t he deqre e of
Master o f Se:iene:e
Department of Bioohemi stry
Kemorial u nive r s i t y of Newfoundland
May, 1 9 9 6
s t. J ohn' s
Newf oun dland
1+1 NalolYlalUtJf ary01canada Bibholheque naloonaledut:.:lnacla
The auth or has grant ed an
Irrevocable non-exclusive licence
allowing the Nation al Libra ry of
Canad a to repro duce , loan ,
distribute or se ll cop ies of
his/ her thesis by any means and
In any form or formal, making
this thesis available to Interested
per sons.
The author retains ownership of
the cop yright in his/her thes is.
Neithe r the thesis nor substantial
extracts from it may be pr inted or
otherwise reproduced without
his/ her permission.
L'auteur a accorde une licence
irrevocable at non exclusive
permettant a la Blbllotheque
naticnate du Canad a de
reprodu lre, preter, distribu er ou
vendre des copies de sa these
de qu elque men tere et sous
quelqu e form e que ce soit pour
mettre des exemp laires de cette
these a la disposition des
person nes Interessees .
L'auteur con serve la proprh~te du
droit d'auteur qu i prot ege sa
these. Ni la these ni des extraits
substantiels de cene-el ne
doivent etre imp rimes au





The g l yci ne cleavag e enzyme complex i s a mi t oc ho nd ria l
e nzy me tha t i s kn own to be act ivated by h o r mones su ch as
g l uc agon . The e f f ec t s of seve r a l g l ucagon -related pept i de s
such as g l ucag on- like peptide- l (7 -36) a mide , ox yntomodulin
a nd g l i c en t in , as well as Rl in i gluc agon , o n t he g l yc i ne
cleavage system were exami ned in i s o l ate d rat hepa tocytes .
o xy nt omodu lin and glicentin were f ound to s timulate the
gl ycine cleavage sys t e m flux through the i r i nte raction with
the g l uc agon receptor. Gl uc agon- like peptide ~l a nd
mini g l ucagon ha d no effect on the glycine c l e a vag e system .
Although the s t i mul a t i on of t he g lyc ine c l ea vag e system
by g l ucagon ha s bee n demonstrated prev i ou s ly , i t is not known
how t he norec na r s ignal is t r an s mitt ed to the mi tochond r ia .
Th is qu estion is ex amined in thi s thesis . The cel l - pe rmea b l e
p rot e i n ph osphatase inhi bi t o r , oka da ic acid , was f ound t o
st imu late the flux through the glycine c l ea v age system. The
prote in kinase A agonist , Sp -cAMPS was a lso found t o st imulat e
t he g lyc i ne c leavage systell fl ux , an effect that wa s inhibited
by the p rotein k inase A antag on i st , Rp- 8 - Br -cAMPS . These
resul t s suggest t hat protein k i nas e de pe ndent
phospho rylation o f c ytos o lic protein {s ) ca n a f f ec t the gl ycine
cleavage sy s t em . The ro l e of intrace llu lar ca l c i um i n the
regulation of t he glycine c l e a va ge system W.:l.S exew tnce using
the calcium-mobilizing hormones , vasopress in and a ng iotensin
II, both of which s timula te t he glyc ine c l e a v age system .
Finally, the r o l e of prot e i n k inase C in t he r-equ La t.Lo n of
glyc ine cleavage s ystem was e xa mi ne d us i ng the phorbo l ester,
Phorbol 12 -myristate 13 - acetate (PMA) . PMA had no effect on
the glycine cleavage system o r on t he qj uc aqon -e.t. Imula t c d
glycine cleavage sys tem f lux, which suggests no ro le for
p rotein kinase C in the a c t i v a t i on of the g l ycine c leavage
s ys t e m.
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Glyci ne is a die tary nonessential a min o ado tha t c an uc
readily synthes ized from common metabolic i r rte raed iaties in al l
organisms . I t is c o ns i de r e d structurally t he s i mples t or omin o
acids, but it has a co mpl e x pattern o f me tabol ism . r c i s
present in high concentrations in collagen and is ab und a n t; in
most animal proteins . Apart from its r o l e in pr-ot ei n
synthesis , glycine plays mUltiple roles in many sv nt hct i c
reactions as shown i n Fig . 1.1-
Glycine is a glucogenic amino ac id. It o r i gi na ll y r e c ei ved
i t s name, r emi n i s c e nt of sugar, because it ha s a s weet t as to .
Conv ersion to serine is the dominant r oute for q l.uconeoqo nos Ls
from glycine . Its conversion to aminoacetone and a u ba oq u.on t 1y
to pyruvate is another potential glucogeni c r ou t e . Hovev o r ,
this route does not appear to be i mpo r t an t i n mamma ls (nc ne e r ,
19 85). Gly cine i s also a major source o f one -ca r bon units with
its c e-car bo n being passed to tetrahydrofolate t o q i ve
methylene-tetrahydrofolate . Glycine condenses with succ iny 1-
CoA to give 5 - ami n o l evu l i n i c acid, which is the precu rsor of
heme, chlorophylls of plants and photosynthet ic bacter ill, and
the c obalamins, notably vitamin 8u and i ts derivat i ve s . It i s
important tor bi le c o n j uga t i o n and in sarcosine, and
g l utathione synthesis. Glyc ine is very important in ea mme j Ien
liver in the conjugation of foreign compounds taken in th e
diet . Benzo ic acid derivatives are metabolized by conj ugation
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I - aminolevulinic acid
with g lycine t o hippuric acid derivatives whic h are excreted
in the ur i n e . It serves in the de t oxifica t ion of salicyl., tes
throu gh th e forma tion o t salisyluric ac id . In a ddit ion , it i s
very i llpo r t a nt in p ur i ne syn t hesis wit h i t s c.u 'bo n
i nco r po r at e d at the numbe r 4 and 5 posi tions of t h e purine
r i ng a nd its ni t r ogen i ncorporat ed a t t he numb e r 7 positio n .
Glyc i ne an d arg i nine a r e used t o fo rm quanidoacet i c ac i d wh i c h
is c o nve r t e d t o c reat i ne . Furthermore, g lyci ne is a ea j o r-
i nhibitory neurot ra nsmitter i n t he s pi na l cord an d b r ain .
Under n o r mal condi t i ons , glyc ine is a none ssential ami no
acid. He....ever, it ha s been proposed that g 1 yeine become s
in d i s pe ns i b l e i n .....ound heal i n g and r eplet i on of t i s s u e a f t e r
dep l e t i on ( Yu e c d l. , 1 9 85 ) . Gl yc i n e is a lso prese nt in 1II0st
pare n t e r a l so l u t ions in l a r ge qu a ntities (S t e g i nk ,./ ,I I . ,
198 3 ) .
ROUTES OF GLYCI NE CATAB OLIS M
D-am..! no acid oxi d.a s e pathway
n -aa tno acid oxidase ca t a l yses t he c o nversion o f qlyc i ne
t o q lyoxylate and NH). Howeve r , t he h i gh KIn of this e n Zyllle for
glyc ine suggests t ha t t his wou l d make a minor c o nt r i b u t io n in
the ov era ll glycine catabolism (Neims a nd Hel larma n , 196 2 ).
Glyoxylate may a lso be form e d from glycine by t r a ns a mi nat i o n
(tlakada an d Sund, 1958) . !.1 mammalian t issues there are two
gly cine aminotransferases: one linked to glutamate/ C/-
ketog luta rate and the ot he r to a Le nfney pyruvate as amino
donorl acceptor. Gly cine i s a very poor sucs ure t;e fo r both of
t hese enzymes and they appear to function in t he direction of
glycine syn th esis rather than in t h e direction of g l ycine
catabolism.
Glyc ine c l e avage enzl''1lle sys t em
Th e bulk of g lycine catabolism in vertebrates is known to
occu r by way of the hepatic glycine cleav a g e system (Yoshida
and Kikuchi, 1972 ; 197 3) . In mammals , t h e glycine c leavage
enzyme system ( GCS) o ccur s in mi tochondria . The overa l l
reaction catalysed by t he glyc ine c leavage sys t em is:
Glyc ine'" THF '" NA O· ---- -----------> CO2 + ~ , I"N -methylene-THF
+ NHJ+ NAOH + H·
Besides bein g a ma j or pathway o f glycine c atabolism in
mammalian t issues. this system is also an i mporta nt source of
5N, loN_met hy l ene _T HF for a variety of synthe tic r ections .
Alte rnative ly, the fa te of me thyl e ne - THF may be to react wi t h
a second mo l ecu l e of g l ycine to fo rm s erine a nd reg enerate
THF. a reaction cat alysed by s e r ine hydr ox y methyltr a nsfe ra s e .
This scheme has b e e n termed t h e "gly c i ne cycl e" (S ne l l, 1984 ) .
Glycine cle avage system i n differen t o rganisms
GCS was f i r s t de scr i bed in cel l -f r ee extracts from th e
anae r obic bac terium fli pl.x(y.:us ,:1)'.:i:l'T.'l .il, 0; (Sngers nnd
Gunsa lus, 1961 ) . Richert e r ,il " ( 1962 ) reported the
occur r e nce of GCS in liver ho mogena t es of p i geon, duc k, and
chicke n whic h were shown to r e le ase the first car bon of
glycine as CO:.
A comparati ve s tudy of glyc i ne ca t a bolism showed t ha t GCS
occurs i n the liver s o f a variety of verte b r ate s pec ies
(yosh i da and Ki kuchi , 1972 ) . GCS was r ep orted i n the l i v e r of
h uman , pig, co w, dog, goat , ra bb i t , gu in ea p i g, fish ,
amph ibians , and rept ile s . Birds and r ep t i l es e xhi bi t t he
h ig hest act i vities among v ertebra te s, while rat pos se sses t he
h ig he s t among ma mma l s.
Glycine cleavaqe s yst em i n rat:
Kawasaki et al., (19 6 6) were the f irst t o re p o r t that ra t
liver mitochondria p ossess t he glycine cleavage enzyme. Li ver
mi t ochondria coul d synthesize t wo mo lecules of g l ycine fro m
one molecul e ea ch of se r ine , b i c a r bona t e , a nd a mmoni a , which
represented the r e ver se of t he g ly cine clea v a ge r eaction . Sat o
e t al . , (19 69) were t he f irst to r e p o r t the r eac t io n i n t he
physiological direction of glyc ine c lea vage. GCS a ct i v ity was
measurod i n different t i ssues of t he rat by Yoshid a and
Kikuchi, (1973). Among the t issues tested, the liver exhibited
t he greatest activi ty while lung, skeletal musc le, and small
intestine had low or neglig ib le activities.
cca location and components
GCS is confined to the inner mitochondria l membrane of all
the tissues tha t h a ve b een studied (Hiraga et " 1 . , 1 972 ;
Ha yas a ka e t a i ., 19 8 0) . The enz y me is l oosely associated with
the inner mitochondrial membrane.
GCS co mpone nts have been iso la ted f rom a number of
bacteric:: (Klein and sagers, 1966), plant (Walker and Oliver,
1 986) , an d a n imal sources (Kikuch i and Hi r aga , 1982) . GCS
consists of f our di f f er ent proteins wh ich are as follows : 1)
a pyr i d oxal p hosp hate-depe ndent glycine de carboxylase; 2) a
l i poic acid-containing al1linomethyl transferase; 3) 5N, ION_
me t hyl e ne-t e t r ahydro fol ate sy nthesising protein; and 4) a
flavin -conta i n i ng lipoamide de hydroge n ase. These p r ot e ins are
referred to a s P-, H- , T - an d L-proteins , r e spe c t i vely . The
g lyci ne cleavage e nzyme comple x requ i res the presence o f all
f ou r prot eins f or i.ts activity.
It is a t etrahydrofolate-depen dent enz yme which ca t a lyses
t he de g r ada t i o n of H- pr otein-bound intermediat e t o ammon ia and
meth y l en e-THF. T -prot ein has been puri fied f r o m the live r of
r a t and its rela tive mo l ecular we i g ht is 3),000 (Mot o k<lwa e nd
Ki k u c hi, 1 974 ) .
It i s a l ip oarn i de dehydroge nase , fl a v i n- cont a i n i ng protein
(Kikuch i , 1973). It f uncti ons to r e oxi d i z e lipoic ac id bac k t o
t h e d i sul f id e form through the transfe r of reduc Lnq
equival ents t o MAD', L i poam ide de hyd roge nase i s a homodime r
with a s u b unit tha t has a r e l ati v e molec ula r we ight o f ab o ut
55, 00 0 ( Ca r ot he rs e t e .t . 19 89 ).
It is a homodimer with a r e lative mole c ula r we i ght of
ab out 210, 000. I t is a pyrid o xa l phosphate-d ependent pro te i n,
responsible fo r t he decarboxylation of the ca r boxy l carbon of
g l y c ine and the t ra nsfer of the. a mi nometh yl re mnant t o t he n-
pr o t e i n. p-pr-otra In is i na cti ve by its elf, it re q u i res the
pres ence o f H-protein f or i t s ac t i vity (Mot okawa a nd Kikuchi ,
19 7 2) ,
H-p rotein is a small , hea t stable , acidic pro te i n that
co n t a i ns lipoic acid as a pr osthetic gro up (Mot o ka wa and
Kikuchi, 1969 a ,b: 1971) . It acts as a c a rrier of the
amI n onet.h y I in t e rmediate be twee n the active sites of the p-
pr c t.e In a nd T-protei n . The r el at ive molecula r mas s e s of H-
prceeme, calcula ted f r om t h e i r sequences, are app ro xima t ely
14 .000 eac h when the l ipoic acid group is included .
The f unct io nal glycine deca rboxylase is an enzyme complex
co nsisting of P- and H-proteins (H i r aqa and Ki k uchi , 1980a ) .
P-prot ein ac t i vity was increased mo re tha n 100, OOO- fol~ by t h e
addi t io n of H-protei n (Hi r aga and Kikuchi, 198 0b).
Mec hanism of ac tion
Fi r s t , glycine and H- prot ein bind to t he P-p rotein a t
se p arate sites b e fore the re l ease o f any p roduct (FUj iwara and
Motokawa, 1983) with glycine forming a Schiff bas e with t he
ca rbonyl g roup of py ridoxal phosphate bou nd to p - pr ot e i n
(Hi raga a nd Kikuchi, 1 980b) . Dec a rboxyl a tion z-asuj, t s in the
release of CO2 (Fujiwara and Motokawa , 1 983) and t he
ge n eration of an H-protei n i nt ermediate. rnen t he methylene
ca r b on of glyc i ne 15 transferred to o n e of t he sulphydry l
grou ps o f t he lipoic aci d pros thetic group of H- pr otein
(Hi raga a n d Ki ku chi , 1 9 90a ) . The methylene carbon is attached
to ' N, lON -methylene-THF i n a reaction c a eaiyeed by T -prot ein
(Fu j i war a e r al. , 1984 ). The last react i o n is the reoxidat ion
of the reduced lipoic ac id of H-protein to i t s d isulfide fo rm.
This step is c a talysed by L- protein , whi ch c o n t ai n s 1',\0 ,1S il
cofactor, and i nvolves the t r a ns f e r of reducing equivalents to
NAO+. The mechan i sm of GCS is illustrated i n rig. 1. 2.
Reg ulation of GCS
Many different mechanisms have been p r o po s e d fo r the
regu lation of GCS .
Bra nched chain g - kgt o acid
Inhibition of GCS by branched ch a i n « - ke t.c acids was
repo r ted by O'Br ien (1978) and Kcc h L ec .-11. , ( 1 986 ). The y
sug g ested that glyc i ne decarboxylase a nd the branched chain n -
keto ac id d ehydroge na s e share a common subuni t which i s t he
lipoamide dehydroge nase a nd t hat t hese o--kato a c i ds e xert
t he ir effects by providing red ucing equivalents to the glycine
c leavage s yste m, pos s i bly through l i poa mi de d ehyd r og ena s e .
Howe ver , t he co nc en trat ions of the branched cha i n (I- ke t o acids
that wer e used i n t he s e e xperiments (2 and 5 mM) are muc h
higher than the ph ys i olog i c al conc en trations Which are 10 -50
JlM ( Sc hauder , 1 9 8 4) . Th e re f ore, i f this occurs i t i s o n ly in
pa thological c o nd itio ns such as t he ketot ic fo rms o f
hyperg l yc inemi a as proposed by o t n r I e n (1978).
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Fig.1.2 Scheme for the overall reaction of GCS
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It has b ee n p roposed that GCS , in Is ot a t .ed pe r f us e d r .lt
l i ver or i n intact rat live r mitochondri a, i s ve r y sensit i ve
t o the o xidat ion - reduction state of t he Jld t o c hond r i a [ttamps on
et d1 . , 1983; 198 4) . Met aboli c n ux throug h GCS in pe r t u sed
rat live r was inhi b i ted b y proces s es that lead to r e duc tion or
the mitoc hondri ll ' N"D( H) r edox c oup l e . I nr us ion of I'·
hydroxybut yrate or oc taoa t e inhibi t ed "C Ol produc t i on from 1-
14 C glyc ine by 33 a nd 50% , respectively . On the o t he r h a nd,
i nfus ion of ac e t oace t a t e , wh i c h i ncre a ses NAO'fNI\1JH,
stimu l ated GCS s ignif icantly an d c omplete l y r e v ersed t he
inhi bition o f H COZ pr od u c t io n b y oc tnnoate . Tn i s ola ted r ,lt
1 I ve r mi t och ond ria it was found that ql ycine ox Lctet t o n
stbl ul a ted in s tat ·· II I when compared to s t eto I V an c
max i mal i n t he unccupt ed s t a te (Ha mpso n , ~t . I J . , 19 B3) .
A.l t e r n a t i ve l y , r espirato r y i nh ibitors su c h as ro tenone ,l nd
r e duc i n g substra tes such as su c c inate , '.l - ke t o g l ut a r a t c , e tc . ,
g r eatly inh i b i t ed t he glycine deca rb oxyl a t i on . I n addi tion,
d i r ec t measu r eme nt of mitocho nd rial py ridi ne n uc l cot ides
showed that t he n ux thr-nu gh GCS was co r rela ted with c h e nqns
in both t he NAD(H) and NA.DP(H) r edox coupl e s .
Howeve r, Sc h a ude r ( 1984) report ed th at feeding a h iqh
protein di et leads t o a n inc rea s e ill th e fl ux thro u g h GCS and
is accompanied by a n i ncrease in the levels o f bra nched c ha ln
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'J - O X O uc Ld and a decrease in t he mitochondr i al N'AD+/ N'AOH
ratio , both o f whi ch would be exp ecte d to decre ase GCS
acti vity according to Hampso n e t: al., ( 1983) . In a ddition ,
Jo i S ,~ I. .11 . , (1 989) s uggest ed t h a t glucagon stimUla t es the
r r u x t hro ugh GCS . Th i s stimul ation ca n not be expla i ned by
oxid at io n -reduc tion s tates o f mitoch ondr i a be cause g l uca gon
res u lts i n ' r ed u c ed r e dox states " of bo t h t he c yt os olic a nd
mitochondr ial py rid ine nuc l eot ides (secane a t ai. , 198 0 :
Ba laba n and Blum, 1982 ).
Dietary prot e in
I s hi k awa, ( 1976) and raeourncu x , (1990) , r-e'por-t.ecl a large
i nc r e ase i n hepat i c uptake o f g lycine afte r f e ed i ng a h .'..gh
pr otei n d iet. However , des p i te this incr ease in th e hep at i c
upt a ke of glyc i ne, its conc e ntra t ion dec re ased in t he liv e r
(Fa f ournoux, 19 90) . Th i s sug geste d a pr i mary a c t I v a -ticn o f
i ntra he pa tic glyci ne me tabo l ism .
Glu c a gon s t i mulates t he fl ux t hro ug h GCS (Jois e z ai. ,
198 9) . Ewa rt et ai., (1 992) reported tha t the s timulat i on o f
CCS by high pr ote i n f eed in g has similar charateristics to t hat
e l ic lted by g lucagon. Thu s , they pr oposed t ha t the high
circulat i ng gl ucagon concentratio n found after i nges t i on of a
hi g h pro t e i n me al (Rob i nso n et ai. , 1981) may be an important
sig na l in st imUlat ing GCS. It was po in ted out by Ewart ec ai.,
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( 1992 ) t ha t i ngestion of a high prote i n diet l oa ds to
i ngestion of a l a r ge amount o f glyc ine which w i ll l end to
increased avai labil ity of f r e e amino acids . Therefore, the
e xcess glyci ne must be catabolized, s t Lmul atl nq the fl ux
t h roug h GCS. Rat s fed 15%-casein meal (normal-p rote i n d i ot )
ox idized glyc i ne at a ra te less tha n 0.15 ornole s ! nll nl mg,
wh ereas for r a t s fed on ece-ce se tn diet ( high-pr-otei n mea l )
the r-at e was 0.38 nmolesl mini mg Or higher (Ew.l.rt ,·t ,I I . ,
1 9 9 2 ) . It has also been repo r-ted t hat glycine c a t a bo Lj am is
s timula t ed in normal protein-fed rats when t he y in g e s t a
singl e high-pr ote in meal 2 hours be f o r e bei ng sncr i f i ce d ,
i llust r ati ng th e r api d r e spon s e of GCS to high protein i ntiake ,
Man y s tudies have show n t ha t the f lux t hrough GCS i ~
r eg ul ate d b y s eve r-c r ho r mones, by h ormone s known t o <le t v t a
CAMP as we l l as by hormones known to act b y i nc r e a s i ng t he
i n t r acel lular calc i um ccnc e nt.re r.Ion. J o i s e t: <II . i ( 1989) ve r-c
the fi r st t o re po r t s timu l a t i on of the flux t hrough GCS by
g lucagon. I n cUba t i o n of iso l a t ed h epatoc y t es with g l ucago n
r esulted i n the stimul a t ion of t he flux th rough GCS i n n erosc -.
depe nd e n t ma n ne r , with a ma ximu m s t i mulat i o n occurring a t. 100
nM glucagon . The s timula t i on of t he fl u x t h r ough GCS by
glucagon wa s also e v id ent i n mitoch ondria isolated f rom rats
1 4
q Lven glucagon, intraperitonea lly, 25 mi nu t e s before bei ng
cec r Lt Icec • Di butyryl-cAMP was al s o equally effective in
s timulating t he GCS flux and a signi fica nt co r r e l ation wa s
observed be tween increased cellu la r c AMP l evels induced by
g lucagon a nd st imula tion of 'ihe flux th r oug h GCS by gl uc agon
(Jois ··r ~l. , 199 0a ) . Jois e t 031., ( 1989) s ugg e ste d two
mech a ni s ms o f action of glucagon on glycine ca tabolis m i n
liver. One i s c ov a l e nt modi fication, by phosphorylation, Which
occurs by activa tion of th e c AMP-stimulated prote i n kinase.
Other kn own t a r get enzymes f or t his mec han i s m include glycog e n
phos phoryl a s e , phenyl a lanine hydr-cxy j a s e , and py ruva t e k i na se
(Garrison et: a1 . , 1984). The s e e f fec ts are l ab ile in that the y
a re readily reve r s i bl e (via pho sphatases) upon r e mov a l of the
ho rmo ne . The s econd t ype o f g l ucagon action i s the s t imulation
of mi tochond ri a l me t a bolism of a v ar i ety o f s Ubstr ate s . Th i s
effect appears t o be fairly s tabl e in t hat i t persists for
so me time a fter t he r emoval o f t he hormon e an d rema ins ev i dent
in mi t o ch ondri a that ha ve been isolated and washe d without a ny
pre c aut i on s t aken t o prese rv e the phosph o r y l a t ion s tate of
p r oteins (Ha l estra p, 1986). Howev er, a l ink between c ha nge s i n
i nt rami t oc hon d r ial funct i ons a nd i ncrea s e d c ytoplasmi c cAMP
ha s no t been est abl Lsh ed . J oi s et: a r.", (1989) s uggested that
gl uc agon st imu l ation o f the f Lux t hrough GCS be longs t o t he
second t ype of ac tion s ince the ef fect i s long and p e r s i sts i n
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mitochondria isolate d f rom gluc ago n in jec ted rats.
I t has been suggested that hepatocytes po s ses s two
distinct recept ors fo r g l uc agon , a GR- l receptor co up l ed t o
st imulation o f inos i to l phospho l ip id breakdown a nd a GR- 2
r e cept o r coupled t o stimu lat ion of adenylat e c yclase a c t tv I ty
(Wakelam et a1., 1986) . Th i s su gge s t i on wi ll be exam ined la t e r
in t h i s thes is . Howev er , Jelinek e c .r1 . , 19 93 iso l a t ed a
complementary DNA clone f or the glucagon receptor by an
expression c l on i r.g strategy , and the r eceptor protein was
exp r e s aed i n severa l kidney cell lines. The c loned recept o r
bo und g lu cagon and c aus ed an i nc ce ase i n the int r acellular
conce ntratio n of c AMP and t ransduced a s i gna l tha t led to
increase in t he intracellular c al c i um .... mcentrati on. No second
g lucagon receptor was detected by J e line k er .-1./. , ( 19 9 3 ).
Therefore, they suggested t hat t here i s onl y one g lucagon
recept or. It may be s imila r to t he calc itonin and parathy r o id
hormone receptors which can t r a ns duce s i g nal s l e ading to the
accumulation of two di fferent messengers , c AMP and calcium.
The flux t hr ough GCS, in Lac Lat.ed perfused rat liver, is
also stimUlated t o 100- 20 0\ ab ove the basa l rate by 1 JtM
epinephrine , 1 JtM norepinephrine, or 10 0 nM vasopress i n (Jois
e t ai. , 1990b ; Brosnan et al ., 1990) . These ho rmones are known
t o exert their effects i n the l iver by i nc r ea s i ng the free
i nt r a c e llu l a r calc ium concent ra t i on. J o i s a t a l . , ( 1990b)
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related the f a c t that glyc i ne i s a gluco neo ge ni c a mi no ac i d
a nd t ha t glucagon, catec holamine a nd vasopressin have be e n
shown to increase hepatic g lucose output by stimulating
g l ycoge no l y s i s and g l ucon eogenesis . rnus , i t is
phys iolog ically i mpor t a nt t hat t he se h ormones s timul a t e the
flux through GCS. I t has a lso been reported that the fl ux
through GCS is s ensitive to concentrat ions of calcium which
wou ld be ac hieved in the cytoplasm of hepatocytes s timulated
by ca lci um- mobilizi ng hormones (J ois at a":., 1990b ) . Although ,
exc lusion o f c a l c i um f ro m the i ncu bat ion medium reduced the
basal flux through GCS in isolated he p a t oc y t es , i t did not
affect the deg ree o f stimulation of flux t h r ough the GCS by
glucagon . Therefore, the abili ty of glucagon to stimulate flux
through the GCS was independent o f the presence of c alc i um i n
the medium (Jois et a l . , 1990b) .
DEFEC'I'S I N GLYCI NE CA'I'J.BOLIS K
Hyperg1yci nemia occurs i n a series of syndromes
characterized by diminished capacity to catabolize glycine due
t o reduced activity o f the glyc ine c leavage system . Nyha n et
,'/1. , (1961) were the fi rst to report the clin i cal symptoms of
hyperglycinemia. Its symptoms were lethargy, convulsive
seizures, prolonged ep isodes of vomit i ng, ke toacidos is an d
abnormally high levels of glycine i n the p l a s ma and urine .
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Hyperglyci ne mia is div id ed i n t o t wo d i st i nct disease s , ketoti c
and nonketot ic hyperglyc i ne mia .
Ketotic hyperqlyc inemi a appears t o be a eecc ndarv
cons e que nce of genet ic di s o r de r s in othe r metabolic p.l t hways ,
particularly those for the bra nched c hai n a mi no ac id .lnd ., -
ke to acids. I t has also been observed t o accompa ny D-qlyceric
i!lcidem i a ( Kolvri!ll!l ez <'1 1 . , 197 9) , ex pe r i me ntal ecdete o f
ph eny l ketonur i a (Isaacs a nd ereene are , 1980) and t he use o f
the antiep ilep ti c drug ....al proic acid (Jaeken cr .1/ . , 1977) .
Se ve r a l mech a n i sms ha ve be en p r opo s ed t o ex p l a in th i s
s y nd r ome . Di rect i nhib i t i on of the GCS by different
metaboli t es was s uggested by O'Brien, (1978 ) .
Nonketotic hyperg lycine mia, which represents ~ he other
t ype of hyper g l ycinemia , is a n i nbo r n error o f ewtnc ac id
metabol ism in which l a r ge amou nts of g l ycine accumul ate in
body fluids . The concentration of glyc ine i s pa rticula rl y hJgh
in t he cerebrospi nal fluid ; i t was r eported to be ten times
h igher t han in norma l s ub j e c t s. Most pat i e nts are se....e rely
mentally r e t arded a nd hav e s eizure disorders . Conv ul sive
s e izure s a nd neu r op eni a have been fo und i n mos t c ases of
nonketot ic hyp e rgl yc i ne mi a . This syndrome i s c a us ed by a r a r e
a utos omal r ec e s s i v e gene . Patients with a defect i n P-, T- , o r
H-protein h a ve been reported (Hirag a, e c ill . , 198 1) .
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GL UCAGON- RELATE D PEPTI DES
The mammal i a n gluc ago n precursor ( p r og l uc agon ) is a 180
amino ac i d pe p tide . I t is pr incipally expressed both i n the
cel ls o f the i s l e t s a t Lange rhans and in the L- ce 1 l s of the
intest i na l muc o s a (Nov a k e e <1 1 . , 1987: Mojsov e c <11 . , 19 86;
oz-skcv e t <11., 1986; 198 9) . The prog 1ucagon gene is a lso
e xp r e s sed i n selected ne u rons of the b rain (Hol st es: <1 1. ,
19 87) .
Molecular cloning of the hamster preproglucagon eDNA (Bell
e c <11 . , 19 83a ) a nd of the huma n glucagon gene (Be l l at a1.,
198 3b ) revealed that it coded for peptides other than
glucagon. The f irs t 20 amino acids form the leading sequence
of the preprog lucagon molecule. I n the pancreatic cells, the
maj or preproglucagon-products glucagon a nd major
preprog1ueagon fragment (MPF) which contains both g lueagon-
like peptide -1 (GLP- l ) and glucagon-like peptide-2 (GLP-2)
sequences (Mojsov et a1. , 1986 : Or s kov e t a1 ., 1992) . In the
i ntestine, the p r-ep roq Lucaqon-edez-Lved peptides i nc l ude
gl i eentin , oxyntomodul in and GLP-l and GLP-2 . GLP-l is further
truncated in the intestine to form GLP-l (7 - 37) and GLP-1 (7 -
36)NH, (Mojsov et a1 ., 1986; 1990; Hol st e t al. , 1 9 87 : Suzuki
et: .'11. , 1992), which are equipotent i n insulinotropic ac t ivity
(Fehmann et .:'1 1 . , 1989 ; Si e ge l et a1. , 1992 a nd ce eer et a1 . ,
1990) . The cleavage of t-he preproglucagon molecule is
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illustrated in Fig . 1. 3.
oxyntomodu l in
cxyntomodulin is a 37-amino ac id pept ide isolated (rom
porcine j ej uno- ile um ( Ba t a i lle e r .11 ., 1 982",). I t i s .1
circulating ho rmone that i s released f r.om the gut dur ing
digest ion . The l eve l of oxyntomodu lin increased by a factor of
two when rats were refed for 2 hou r s after a t a -nour-s fast ing,
reaching 23. 3 ± 3 . 0 prncLy L (Kervran c r .11., 198 7). It
d isplays tissue specifity co ntrasting with that of glucagon ,
which possesses biological activities d irected towards the
tissues imp licated in fuel homeos tasis. OxyntomodUl i n 's mai n
target tissue is t he qastric mucosa ( Ba t ail l c et .11 . , 1981),
where i t i nhi b i t s gastric ac id secretion a t doses that are 1 5-
t old l owe r t han t he effectiv e doses o f glucagon i n the
anesthet ized ( Dube rasquet et el , , 1982 ) , or co nscious rat
(J a r r ous s e e t: al. , 1985: 19 86 ), a s wel l as in human s
(Sch j o l d ag er et al. , 1988 : 1989) . oxynt omodulin contains t he
glucago n sequence ex tended by a C-termi nal bas i c octapeptide:
Lys -Arg-Asn- Lys -Asn-Asn-Ile-Ala ( Ba t a i lle et ill. , 1982b ) . The
molecular basis fo r oxyntomoduli n sp eci f icity res id ues in the
coox - ter mi nal octapept i de, which differentiates it from
g lucagon. This octapeptide mi mi c s the b iological act ivity of
the ho rmo ne . It was s hown t o inhibit histami ne -, mil k mea l - ,
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Fig. 1.3
Schematic representation ofthe preproglucagon molecule
(Thom es and w aeber , 1993)
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or pentagastrin-stimulated gastri c secretion in cons c i ou s r ats
provided with c hr onic f istu lae (Ja rrousse ~3 t ,il . , 1985; 1993;
Carles-Bonnet e t: a1., 19 92). The mode o f action of
oxyntomodulin on gastric muco sa i s controvers ial . Al t hough a
good inhibitor of gastric acid secret ion it increases the
adenosine 3 ' , 5 ' - eyej I c monophosphate levels in isolated
f und i c g lands (Ba t a il l e e t: aI. , 1981; 1988 ), a characterist ic
shared by h istamine, which i s a ma j or stimulant of ga s tr ic
acid secretion ( Cod e , 1982 ).
It has also been reported t ha t oxyntomodul in st imu lated
insu l in re t ease monophas i ca llY i n the presence of low (6 mM)
med ium g lucose c oncentration. Furthermore, o xyntom od u l i n
po tentiated g l uc os e- i nduc ed insu lin release ( 10 mM g lucose ) i n
a dose-dependent manner, althoug h it was l e s s po ve r EuI tha n
s imilar co nc e nt r a t i o ns o f g lucagon (Jarrousse e c <1 1 . , 1984 ).
Th e effects of g lucagon and oxyntomodulin on b lood glucose
leve l were compar ed i n r at. During t he course of glucagon
i n fusion, a t a dose of l. 8 nmol l Kg, blood glucose was
incre a s ed 2- fold while the same dose of oxyntomoduli n induced
on ly a sma l l, although s i gni fi c a n t , increase over the control
ba sa l values . It was ne c e s s ary to increase the ox yntomoduli n
d ose IO - fold to p r od uce the same deg ree of hyperglycemia as
that i nduced by glucagon (Ke rvran et al ., 1990) .
"
GLp· l
GLP-l is an intestinally derived hormone from the glucagon
family of pept Ldaa . GLP-1 is found in four varients:
proglucagon- 78 -108, GLP-l (7 -37), proglucagon-n-l08, or GLP-
1 (1-37), and t he i r respective amidated forms . Purification o f
GLP- l from human a nd p ig intestine and its analysis revealed
that the majo r naturally occuring peptide corresponds to
proglucagon (78 -107) NH: , or GLP-1 (7-36) a mi de (Kreymann et
al., 1988 : Orskov et al., 1989) .
GLP-1 secretion is stimula ted by ingestion of a mixed meal
and its plasma concentration varies wi th the meal patte r n
(El liot e c al . , 1993: Orskov e t al ., 1994 ) . GLP-l levels
increase from 1-10 pmol / L to 20 -50 pmol/L after ingest ion of
a mixed mea l (Ors kov et: al., 1994) . Significant increases in
GLP-l levels may occur a fter a f e w minutes, a nd pe a k values
may be reached 15 -30 mi nutes af ter ora l i ntake of a stimulus.
GLP-l (7 -36) a mi de ha s profound effects on the e ndoc r ine
pancreas in mammals . I n physiologica l concentrat ions, GLP- l
stimulates insulin (Mo j sov er a1., 1987 1 Holst et a1 ., 1987:
Orskov an d Pou lsen, 1991) and somatostati n secretion a nd
stro ngly i nh ibits glucagon secre t ion (Holst et al., 1987;
Orskov et a1 ., 1988) . I t s effect on insulin secretion is
g luc os e - depen den t . Howev er, GLP- 1 i nfused intraveno us ly i n
physiological a moun ts en hances i nsulin secret ion s ignificant ly
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at euqrycemre (in the f a s t i ng and/ o r postabsorpative state)
in humans (Or s kov e c a l ., 199 3; Hvidberg c t ,11. , 199 4) . Not
only does GLP- l Sltimu1ate insul in release (Wei r ec al. , 198 9) ,
but it a lso st imu lates the expression of the proinsuli n gene
and proinsulin synthesis ( Fe hmann and Habener, 1991 ). The
half-l ife of GLP- 1 infused i n t r a v e nou s l y into huma ns i s about
5 minutes, and the metabolic c l e a ranc e rate ha s been
calcu lated to be approximately 13 mIl Kg/ min (Or s kov e e .1./.•
1993) . Therefore, the pept i de seems to be rapidly and
effectively removed f r om the c i rculation . The kidneys seem to
play a r o le in t his process since GLP- l was eff i ciently
extracted by i s o l a t e d perfused r a t kidneys (Rui z- Cr a nd e os;
a1 . , 1993) . Orskov et a 1 . , (1992 ) ha ve reported high levels o f
plasma GLP-l in patie nts wi th renal fai lure i nd i cate the
kidneys contribute t o GLP-1 elimination, i n vi vo .
Expre s sion c loning o f the pa ncreatic a - ce c e pcc c of GLP-l
has been reported recent ly (Thornes, 1992: Tho r nes and Waeber,
1993). The receptor belongs to the s even-transmembrane, G-
protein coupled superfamily o f receptors . Its affi n ity fo r
GLP-l , as i dent i f i ed by binding t o cloned receptors
trans fected i nt o va r-Ious cell l ine s , cor re s ponds t o an
aff inity co ns tant appro x i ma t ely 10" mol l L, and the binding
i s high ly s pecific f or GLP- l (Hj o r t h e t a1 . , 1994 ). Glucagon
may bind to t he receptor but wi th affinity at least i cc -eere
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l e ss than GLP- l, \Jhlle no ne of the pe pt l des of t he qlucagon -
secreti n f a mily bind to the receptor ( Hols t , 19 94 ) .
Extrapancreat ic GLP- l receptors ha ve been i d e nti f i e d i n rat
brain , k i dney, a nd s kele t a l muscle (Whee l e r et: al ., 199 3 ) .
xen se ee al. , ( 1988) reported displ<:tce able binding o f GLP- l
(7 - 3 6 ) amide to ho mog e na t e s of rat l ung and brain.
The i n t e rest i n GLP- I with respe ct t o d iabetes mellitus is
be ca use of its effects on i nsulin s ec retion and i t s ability to
lowe r blood q Iucoae , In p a t i e n t s with type II diabetes,
i nfusion o f GLP- l e limi na t e d postprandial g l ucose e xcu rsions
f o r 60 minutes after a mi xed mea l (Nathan e c al ., 1 9 92 ) . In
patients whose blood g lucose l e ve l s were r eg ulated , near
physiological aacunt.s of GLP-I infused during ingest ion o f a
mixed me a l ",:oarly e l imi na t e d i ns u lin r equirements i n these
diabetic patients (Gutnil!lk e t ill ., 1992 ). Moreover . in poorly
co nt r olled pat ients with type II d i abetes, a GLP-l infusion of
1. 2 pmol l kg / lIi n completely normalized b l ood. glucose lev e ls
wi th in 2 -4 hou rs (Hauck et a.l . , 1993)
Glieentin
Gl i cent in has been isolated f rom porcine i ntest inal mucosa
(Sundby at al ., 1975 ; La r s son and Moo dy , 1980 ) . I t ha s b ee n
sugges t ed that glice nt i n i s a. prohorn one to g l ucagon (J ac obsen
e e al . , 1977) or t o other fragmen t s wi th glycogenol yt i c
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properties (Ho l s t, 1978) . The c i r c u l a t i ng level o f p Laema
glicentin r eac he s approximately 1 nM f ollowing nutrient
inges tion (Ohneda, 1987) , a concentration wh i ch i s far higher
than c onc e ntrat i on s of t he other gastrointest i nal ho rmones .
It has been repor ted that the g lucagon-secreting A ce l l s
of t he pa ncreas c ontain a glicentin-like peptide which i s
l o c a t ed in the secretory granules (Moody e t: <11. , 197 7 ;
gava z zoi.e e t a1 . , 19 79 a, b ) . The phy s i o l og i c a l a ct i on of
g l i c e n t i n is not co mpletely understood . Glicentin was fo und to
have no effect on basal insulin release in t he mouse, it
i nhibited glucose -induced insuli n secretion (Ahre n and
Lundquist , 1980). Recent ly, Ohneda e t a1. , (199 5) have
demo nstra ted an i nsu l ino t r op i c act ion of g l i c e n t i n
pancreatic a - c e t i e i n do gs . Although these e ffects of
g licentin ha ve be e n reported, t he actua l mecha nism of i ts
act ion remains t o be invest i gated.
Hiniqlucaqon
I t has been sh own t hat i nterac t ion of g lucagon with liver
cel ls l ead s to the cleavage of the hormone by an endopep tidase
giving r i s e to t he l oc a l pr oduc t i on of t wo COoH-temina l
f ragme nts (Mallat et a 1 . , 1987 ; Bl a ch e e t a 1 . , 1989) . glucagon
( 19 -29). r e f e r red t o a s mini g l u c agon by Unge r a nd orc i,
(1990), and glucagon ( 18-29) . Gluca gon (19 -29) is presen t in
2.
rat pancreas and stomach; i t s tissue co nc e ntra t ion cor r es pond s
to ab out 3% of that o f glucagon but t here are no detectable
amounts o f the pept ide i n ra t 9lasma (Blache et: al . , 1990) . I t
h as been s hown t hat g lucagon ( 1 9-2 9) i s generated upon
incu ba t io n of glucagon with l ive r p lasma membranes a nd was
degraded with a ha lf-life of < 10 s eco nd s (IH ache e r a1.,
1990) whi ch may exp lain why, unlike glucagon , g l ucagon (19 -29 )
i s not found i n the circulat i on . Rather if i t is
physiolog i cally active it mus t be produced lo cally at its s i te
o f action . The en zyme , or enzymatic s ystem, responsible f or
miniglucagon produc t ion is a thiol en dopeptidase . Bl ache et
d1., ( 1990) reported that mi n i gl uc agon p r od uct i on wa s
inhibited by thiol -reactive agents such pa ra -
chloromercur i b e nzoa t e , N-ethylmale i mide and para-
c hloromer curibenzenesulfonate . Partia l inhibition by the
c helating agent 1 , 10 ~phenanthro line suggests that the enzyme
a l s o Lnc'I udr.s a catalytically active metal, wh ich contributes
to t he full express ion o f the enzymat ic activity .
Glucagon (1 9-29 ) and glucagon ( 18-29) , at nanomolar
concentrations, inhibited t he act ivity of t he plasma membrane
calc ium pump of l i v e r plasma me mb r a nes wh i c h i s responsible
for the ac t ive e xt r usion of calcium from the cell eBl a c he et
al., 1990) . Minigl ucagon exerted a biphasic s t imulation on
this s ystem i n l i ver (Lo tersztaj n et al. , 1990 ) where i t was
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1000 times more e r rect.tve than glucagon itself". Bot h pe ptides
have no effect on adenyLyL cyclase ac tivity, but it h<lS b ee n
reported that t heir act io n on the c a l c ium pump i s med iated by
cholera t o x i n- s en s i t i v e G protein(s) (Lotersztajn .~ t ,1.1. ,
1990 ) . The demonstrat ion that glucagon i t se l f can be processed
i nto a fragmen t wh ich displays an ind iv idual b Lol cq Lc n I
spec i fic ity, na mely t he r e gu l a tion of" t he membrane-bound
calcium pu mp , ra ises t h e quest ion of t he presence a nd natu re
of rec eptors ten: t h is pe pt i de o n l ive r plasma membra ne . Any
metabolic actions of min ig lucagon ill vivo r e ma i n to be
eluc idat ed .
GLUCAGON RE CEP TOR ANTAGONI ST S
I nc r eas ing interest in t he role of g lucagon in d iabetes i n
t he maintenance of e l e va t ed b l ood g lucose levels has made the
d eve lopment of glucagon antagonists v ery important.
Furt hermore, a pure an tago nist o f glucagon wou l d be a valuabl e
t oo l f or i nvestigati ng t he mechanism of" i t s biolog ica l
ac tions . Ea rlier s truct ure-function studies have. been directed
at e lucida ting the funct ional groups a nd the conformat ional
features o f the hormone t hat are responsible for recognition
and b ind ing f rom thos e t ha t t ransduce t he b iological response.
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D89-H is'-(Glu' j-glucagon ami d e a. ;d i ts b i ologica l a c t i vi ties
Des -His'- [Glu~] glucagon amide was proven to be a
relatively potent competitive antagon ist to glucagon in
hepatocyte membranes (Unson et: <1 1 . , 1987). Its b ind i ng to the
receptor, as measured by competitive displacement of lU I _
labeled glucagon from live r membranes, was approximately 40%
as e f fective as g lucagon itself . Moreover, t his analogue did
not activa t e adenylate c vc rase or generate cAMP at any of the
conce nt r a t i ons tested .
Post e r <1 1 • • (199 3 ) i nv est i g a t e d the activities of des -
His' - (Glu'] g lucagon ami de c ompared to glucagon in modu lating
the a ctivity o f ade ny lyl cyclase i n isolated intact and
saponin-permeabilized canine nepeeccytee . The antagonist , at
30 nM, was able to i nh i b i t by 50t the cAMP accumulation
induced by nM glucagon . In s aponi n-permeabilized
hepa tocy tes, the an tagonist at about 100 nM inhibited by 50%
the stimulat ion of adenylyl cyclase that was induced by 10 nM
glucagon . In both i nt a c t a nd saponin-permeabilized hepatocytes
the antaq o n Ls t; was without effect on the basa l act i v i t y of
adenylyl c y c l a s e . These results identify the analogue des-
Hisl- [G lu~] glucagon amide as a t r u e antagonist of g lucagon
action i n b ot h experimenta l preparations i n vitro .
In I"i vc ef f ects of the antagonist were reported by o ne en
e r d l. . ( 1989). De s - Hi s 1- [ Gl u' ] glucagon amide did n o t
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appreciably stimul ate g l ycoge nolys i s in fasted rabb its at
c onc en tratio ns more tha n 40 0 tim es t he c cncent.re t Io n of
glucagon required for a measurabl e effect . More over, when t he
an alogue was a dmi n iste r ed intravenous ly to normal r abbits i n
a mixture with the na t ur a l hormone at a r a t io of 100: 1 it was
able t o supp r ess almost c ompl e t e l y the hyperg ly cemi c effect of
the added g lucagon . In s trept ozotocin- induced diabetic rats
the a ntagonist caused a 6 0 - 7 0% decr ease i n blood glucose
(Unson et a1 . , 1989) .
De S_Hi s 1_ [ Nl e '_Alll ll_1r.lau ] glucagon llmi4e
In a n effort t o understand and max imize the structura l
f ea t ur e s that cont r i bute t o gl ucagon r e c epto r an t agonism, many
analogues of glucagon were sy nthesized incorporating t he des-
His1- [G IU' ] a nd the CDaH-terminal a mi d e substitut ions . Their
abili ty to compet e with glucago n fo r receptor b inding and
adenylate c.ycreee ac tivation were measured. Unso n and
Merrifield, (1994) sj.ec uraeec that a serine residue might
cooperate wi th His1 ..md ASp' to produce an ev.t.Ive center . Suc h
a pu t a tive His, Asp , Se r ac tive s ite would be reminiscent of
t he serine p ro t e ase triad . Glucagon con t a i ns four s erine
r e sidu e s a t p os it i o ns 2 , a , 1 1 , 16 , which a r e cons e r ved among
t he members of t h e family . They t es t e d for the requirement for
serine by a ser i es of s ubs t i t utio n s fo r t he h ydr oph i li c
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hydroxyl group i n each of the fo ur positions . Whereas neither
s erine 2 , II, nor 1 6 are requi r ed for rece ptor r e cogn i t i on,
t h e y s howed that seri ne 16 is essential f or signal
t r a ns duc t i on and s uggested that it may be the third residue in
g l ucago n to pari:.icipate in the pu tative catalytic triad
(together wi th aspartic acid and histidine 1 ) i n t he
transduct ion of glucagon 's re sponse . unson and Me r r ifie l d ,
(1994) a pplied comp uter g raphics to t his problem. Usi ng t he
work i ng mode l o f gluc agon in dllute so lutions, they foun d t hat
His" Asp~, and Serl6 side c hains could be j uxtaposed to create
the hypothetica l c ha rge r ela y triad. T hey suggested tha t t he
g lucagon -receptor c omplex acqu ires e nzyme activ ity upon its
formation a n d that t his activity mig h t i n i tiate t he
transduction proce s s.
When g lu t am ic ac i d or the hydropho bi c ami no acids
leuc i ne or norl eucine wer e sUbstituted fo r aspa r tic acid at
position 9 a nd 21 analogues tha t boun d well with partial or no
a de nyla te cyclase activa tion we r e p roduc e d tuns on e t aJ .,
1991) . Al ani n e a t posi tion 1 1 was repo r ted t o increase
receptor bind i ng af f i nity nea r ly 5-fold (Unson et a1 ., 1 9 94) .
Consequentl y , de r ivatives incorporating these amino acid
substi t utions were s ynthes ized a nd combined wi t h t he de letJ.on
of histidine at position 1 (Unson et a J., 1989; 1 994) . Among
t h es e analogu es was des -Hisl- {Nle'-Alall-AlaUj gl ucago n a mi de
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whi ch bo und as we ll o r bette r th a n gluc a g o n i tse 1t ,
o n CAl e ACID
Okadaic ac id i s a polyether ceetve e tv e of a a a-ca rbon
fatty ac id original ly i solated t r om t he b lack sponges
Hdlichond :::-ia Okd d ii and Halichcndria me1.3 ncJoci a (Tac hibana ..~t
131., 1981) . I ts structur e i s give n i n F i q . 1 .4 . As a aar Lne
t oxin, it i s impl i cate d a s the causative agent of diarrhoe ic
s he l lf i s h p oisoning, (DSP) . It i s kno....n to be one o f a fa mi l y
of related t o xi n s i n c l udi ng d inophysistoxi n -l a nd
acanthifolicln . S uc h toxins are s y n thesized by dinoflagellate s
(ma ri ne plank.ton ) , e special l Y o f t he genus oiroonvoto, but
the y a c c umulate in orqan i sms fu rthe r up the food chai n ,
incl uding sponges , she l l f ish and , ulU _ate 1y. h UlIlans , causi ng
DSP (Ha r die e e 131 . , 199 1). The firs t i ns i g ht into i t s
me c h a n i s m of a c tion came fro ll ceeervec t e ee t ha t it enhanced
the contrac tion of iso l ated vascula r smoo th llIus c l es fro" human
umbilic a l a rteries a n d r a b b it ao r ta (Co h e n and cohe n , 1989 ) .
Later , i t was s h own tha t i t i s a potent and specific inhi bi t or
of p ro te i n phospha tase 1 ( PP II and prote i n ph osphata s e 2/1
(PP2A) (Taklli e e <!l . , 1987 ; I s h i h a r a et d J., 1 989) .
cxada Lc acid ha s been shown t o ac t as II tumour promot er i n
the mouse ski n bioassay I but unlike many other t umour
promoters i t does no t ac t iva t e prote i n ki nase C (S u gfmuma e r
J2
Fig. 1.4 Chemical structure of okadaic acid
C)-'yClv·y--,,.. ~::o-.x ..
·v " ;y-.~ y. IJ
Okadaic Aci d
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al ., 19 8 8) . Because PP1 a n d PP2A are l. i ke l y t o be the chief
e n zymes t hat r everse thr. act ion of protein kinase C, it i s not
surprising t ha t okadaic acid should be as p ot e nt a tumour
promoter as t he pho r bol esters which activa t e pr o t e i n k i nase
C. Tumo ur p rceoe Lcn p r obabl.y ste ms f r om increased
phos phory l ati on of one or more pr ote i ns tha t a r e z-eaquja t o d by
prot ein kinase C an d are d ep hosphorylated by PP1/PP2A.
Okadaic acid i s a v a l uabl e t ool to t est t he ro l e of
prot e in phosp ho ry lation i n a ny phys iological r-eepone e in
int act cell s s Lnce it is cell-pe r meable . PPI and PP 2A a r e t wo
?f th e fo ur maj or p rotein phospha t as es i n the cytosol of
ma mmalian c a lls t ha t de p hospho ry l ate serine an d threon i ne
res i dues (Coh e n a nd coh e n , 1989) . Protein p hosphatas e s are
subdivid ed i n to t wo t ypes with t hr ee subt yp e s of t ype 2 . PPI
dephos phoryl ates the a - s ubun i t of phosphoryl a s e k inas e
specifi c allY . PP2 dep hospho r y lates the a - s u buni t of
phosph orylase ki n ase pre f er ent i ally . The mechanism of
p ho spha t ase i n hibit i on by oxe da Lc acid is unknow n. Remol rka bl y,
the sensitiv i ty o f PPl and PP2 A·to okada ic acid has been
conserve d, a n d is i dent i c a l in org anisms a s di ffe re n t as
ma mmal s, yeas t , f r ui t flies , starf ish , a nd higher pla nt s
(cohe n a nd Co hen, 1989 ; Co hen et i./1. , 1990) .
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Oltadale acid as II. probe fo r identifying biological processes
t h at a r e controlled l:ly ph o s phor yl ation
Si nce okadalc acid is hydrophob i c . i t c an ent e r isolat ed
i n t act cells a nd he lp reveal phy s io log ical p rocesses th a t ar e
control led by phosphor yl a t i on/ dephosp ho rylation mec hanisms.
Ckadaic ac i d p r oduces a ma r ked increase i n t h e phos p hory l ation
of many pro te ins i n adipocytes and hepatocyt es ( Haystead ez
.,]1 . , 1989) . Ma ny o f t hese pro teins a r e cyt o s olic enzy me s of
g lucose and l i p id me tabolism, such as acetyl Coli c a rbo xy lase ,
ATP- c i t r at e l yase , 6- phosphof r ucto-2 -kinase/ fructose-2 , 6-
bis pho sphatase and pyruvate kinase . Ph osphorylation of
g lycogen s ynt hase and gl y cogen phospho ry l as e is i ncrea s ed i n
the he patocyt e gl yc o ge n f r ac tion .
spaciricity or olca d aic acid
All effect s of okada i c aci d on intact ce l ls ar e maximal a t
1 JLM, wh i ch is simi l a r t o t he c oncent r a tion of PPI a nd PP2A i n
( Hays tea d e r a l.. 1 989) . Okada ic ac i d specifici t y is
emp has ized by i t s fa ilure to inh ibit pro tein phospha tas e 2C
(P P2C). mitochondrial p yruvate de hy d rog e n a se phos phatase,
protein t yr os i ne phosphatases, ac i d and alk a l i ne p h osph atase s
and in ositol triphosphatase (Bialoj an and Ta k a i , 1 9 88) . It has
n o ef f ect on othe r phosphatases suc h as the othe r t wo major
protein-serine/ t h r eo ni ne phosphatases, t he Ca2·/calmodu!in-
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de p end ent pr ote i n phos phatase 2B (PP 2B) a n d the Mg:'-d e pende nt
PP2C (Bi a l oj a n and Takai , 19 88) . o xadatc a cid h a s no e f f ec t on
a v a r iety of pro tein k i nase s suc h as c AMP or CaZ' j ca lmodu l i n-
de p endent prote in ki nases, or pro tein k i nase C ( Takai ,·r d I. ,
19871 Haystead et: ai . , 1989),
CYCLI C AMP ANA LOGUES
I n euka r yotic cells, c AMP is a majo r int r a c e llula r second
messe nge r th at mediates the effects of hormonal or ne rve
s timul a t ion . s ince cAMP ha s poo r cel l permeabili t y "nd is
r e a dily h ydr olyzed by ph osphod iesterase a number of analogues
wi t h be t t er ce ll pe r meabi l i ty and a l o n ge r b iol og ica l l ife
were us e d i n intact cell s (Pa r k er-Bo t elho e c ,1/ . , 1988).
Cyclic a denos i ne-J ', 5 ' - monop hos phothiorate , CAMPS , is an
a n a lo gue of cAMP i n wh ic h one o f th e t wo e x ocycl ic oxy gen
a t oms i n the c y clic phosphate moiety i s r epl aced by s ul phur .
Equatorial or axia l th i o subst i tution leads to R- and s -
i somers , r es pectively (Fi g . 1 .5) .
The S p -d i ast eraome r , Sp-cAMPS , is a cAMP- depe ndent prote i n
ki nase a gonis t wh i c h binds to t h e holoe nzyme with
approldm a te ly 1 0 ~ o f t he bi nding a ff ini t y of c AMP a nd
activat es th e enzyme ha lf malo:1mal ly at 0 .3 IJM (Rot he r mel at
al •• 1983). Rp- cAMPS i s a cAMP -depe n dent protei n kin a se
an t agoni s t and the f irst r eported c AMP ana logue which compe tes
l6





with cAMP for binding sites on the regul atory s u b u ni t without
c a using dissociation of the holoen zyme (d e Wi t cc .d . , 19 82) .
This is attributed to the i nab il ity of this c ompound to induc e
the regul atory sUbunit c onf ormational chang e n ece s s a r y t o
release the catalytic sUbuni t. since the Sp- isomer behaves a s
a cAMP agon ist, it wc s suggested that the holoenzyme
d issociat ion depends on t he formation of a !';alt bridge betwee n
a positively c ha rged amino acid s ide ch ai n a nd the equatorial
exocyc n te negatively charged oxyqen wh i ch h a s bee n r eplaced by
a su lphur a tom i n Rp-cAMPS (d e wi t et .~1. , 1982) .
The Sp- an d Rp -diastereomers Df adenosine cyc l Lc -u t , 5' -
monophosphorothioate, Sp -cAMPS a nd Rp - cAMPS, a re u se fu l t ools
for stUdying cAMP- depe n d e nt control of many rate-l im iting
enzymes i n the liver . Bo t h ana logues enter isolated
h e pat o c yt e s readily and are resistant to t he a c t i on of
i n t r a c e llul a r phosphodiesterases within the t ime frame o f most
experiments (Rot h e rme l e c il l . , 1983; Meserve e c <11 . , 1986).
Therefore , intracellula r con centrat ions of the ana logues are
constant t h r oughout an experiment and p roduct ion o f
metabolites is o bviated . In hepatocytes i solated from fed
rats, Rp-cAMPS i n h i bits t he Sp -cA MPS-i nduced (Rothermel e t
Cll . , 1 9 83) and glu c agon- i ndu c e d activation of cAMP-de penden t
prote in ki n ase a nd the consequent effects o f ph osphoryla tion
of t h e enzymes controlling b o t h the glycogenolytic cascade
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(Rothe rmel e c -31. , 198 4a ) . Meserve e t: al . , (1 98 6 ) reported
i n hi b i t i on of he.patic gluconeogenesis by Rp-cAMPS.
specificity of Rp-c,,"PS
Several observat ions suggest tha t Rp-cAMPS is s pecific fo r
cellular cAMP-dependent p r otein ki nase and that it has no
other intr insic biochem ical properties . First , Rp -cAMPS does
n ot act iva t e phosphod iesterase nor is i t met abolized by
p hos ph od i es t e r a s es , ru l ing out the product i on of a ct ive
metabolites (Jarvest ec a 1 . , 1982; Van Haas tert e t ai. , 198 3).
Second, Rp-cAMPS does n o t affect t he basal lev e ls of cAMP-
dependent prote i n kinase (Rot h e r me l et a1. , 1 9 8 3 ; 1984b) ,
p hosphorylase, py ruvate ki nase , and glycogen syn thase
(Rothe rme l e t 031. , 1984 b). Fina lly, cAMP-dependent p r o t e i n
kinase is the only physio l ogically significant c AMP- binding
prote i n in mammal ian cells ( s c nvcc n a nd Helz , 1977), other
tha n ph os ph od i es tera se , ma ki ng it the most likely t a r g et for
Rp-cAMPS.
CALCIUM-MOBILIZING HORMONES
c a lcium-mob iliz i ng hormon es such as vasopres sin an d
angiotensi n II induce resp onses in he p a t oc yt e s and other ce ll s
t h rough activation o f a gua ni ne nucle o t i de-bind i n g protein (G
protein ) t ha t r egu l ates phosp ha tidyl i nozito l 4,5 b i sphosphate
3 9
(PI P.) breakdown (c e rebe e : .11. , 198J ; Thomas .' t .t : • 19 8 J :
19 8 4; Berridge , 198 4; Exton , 1 988), The r es ul t i s the
generat ion o f inositol 1 ,4,5- tri phos ph ate (IPl ) and 1, 2-
diacylg lyce rol, ....h ich i s fo rm ed conc omitantl y wi th IPJ a nd na s
p reviou s l y be e n shot...n to activate a ce" - a nd phosp holi pid-
dependent protein k inase C (Ki shimoto et: .J!. , 1980 ; Ni l'lhizuki\ ,
1984a ,b) . The s e hormones a ct o n t he int r a cellu lar ca l c i um
c o n c e nt r a tion and glycogen pho s p hory lase part ly by r-e I ee e i nq
ca'" f r om i nternal s t o r es ( Ex t on , 198 1; Re in hart es: . 1 I " 19 8 ,1)
and by augment ing the entry of ex t r ace llu l ar Ca l> ( Ke ppe n s
al. , 19 77 ; Reinhart et: ai . , 198 4; Maug er <:'1. .11. , 1984 ) .
Va s op res s i n is known to stimulate glucose out p u t i n re t
liver ( Hems and Whitton, 197 3 ; Hems e r .11" 1 976 ) . It
stimulates g l y coge n b r ea kd own and gluconeog ene sis in t he r a t
liver at conc e nt r a t i ons (0 .1-1.0 ng/ml ) whic h occu r i ll vivo.
This hepati c action of vasopressin , i s i mpo r t a nt i II vi vo , in
cond itions where plasma vasopressin levels a r e high such as
haemorrhagic shock (Kirk and Hems , 1974 ) . vasopressin c a uses
act ivation of liver glycogen phosphorylas e, the ra t e limi ting
enzyme for glycogenolysis (Keppe ns and DeWulf, 197 6 ) . St ubbs ,
e t: 03 1. , (19 76) have shown that the action of vasopressin Is
very sensitive to extracellular calc iu m an d i s also partially
diminished in the absence of extracellula r K· and she was the
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fi r s t t o suggest th at ca t i o ns and c al c ium in pa rticular are
lik e ly to be i mplicated i n va s op r es s i n ac t i on o n live r
g ly c o gen metabol i s il.
Exper i ment s i n vl v o and in Vi C':"Cl show ed tha t ang i o t ens i n
II s h ares the glycogenol ytic prope rties of vasop re ss in , both
t or t he i n t act rat and t o r t he pe rfused l i ver (Hems a nd
Wh i t ton, 1 9 7 ] ; Ma and He as , 1 9 75 ; 1<eppens an d DeWUl f , 19 75 ;
Hems et ,ol . , 19 7 5) . Keppens a nd DeWUlf , (19 7 6 ) r eporte d that
t he c oncent r at i on s o f a nqi o t e nsi n II fo u nd to a ff ec t liver
gl ycog en p h ospho r yl ase a re like l y t o occur dur ing haemorrhag i c
shock . A h a lf-max i mal activat ion o f glycogen phosphor y lase was
obt a i ned i n iso l a t ed h e pat oc ytes a t abou t 0 . 3 ng angiotens in
II I mL I t has a lso been reported th at modera t e hae mo r rhage
sho c k (wi t hdrawa l ot 14 - 26 ml bloodl 1(9) resul ts i n an
in c r e a se o f the c oncen tration of a ng i ot en s i n II t o 0 . 3 3 09/ ml
bl ood in d ogs. S t i llul a tion o f g l uc oneoge nesis b y vas o p r es s i n ,
and a ngiotens in II has been reporte d in h ep atocyt e sus pensions
(Wh i t t on et 011. , 197 8 ) . The he pa t i c gl ycine c l e ava g e sys tem
has bee n reported t o be s t imu l at ed by va s o pr es s i n (Br o s na n ec
ill . . 1990 ; Jo i5 e t: al .• 19 9 0 bl .
Stimul ati on o f gl ucose out put by vasopr e ssin a nd
ang iot ens i n II i n t he l i ver cell s is cri t i ca ll y depe ndent on
t he cake fun concentration (StUbbs et al. , 1976; Whitton e t
<1 1 .. 197 8 ) . vasopressin was found to have no effect
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.ad e nyLy L cyclase ac tivity . No i ncrease in cll.MP W<lS detected in
the l iver or per f usate i n r e s ponse v nsopr-o as i n
concentra t i o ns that were maxim a l or a uprnma x i maI with r-e qa r ct
t o the ir effect on g lucose ou tput (Ki r k ,10d uems , 19 7-1) . trees
e t: ,'/1. , (1978) fo u nd no increase i n the hepati c co nte n t o f
cA MP or cGMP ",a s after the addit i on o f vas op ress in o r
angiotens in I I . Neither v asopressin n or anq Lote ns Ln rt a r ro c t s
p rot e i n ki n ase A a ct iv ity i n the l i v e r t xe ppe ne a nd Dewut t ,
1 9 7 5 ; 1 9 76 ) .
Ho wever , t he c a lcium mes s e nge r and c AMP s y s t e ms iH'C t o
some e x t ent i nterdepe ndent i n mamma l i a n 1 iver . vasopressin
st i mula t i on o f ino s itol phosphate a cc umu La t Lon i n t eo ta t co
hepato cytes is enhanced by cyclic AMP-de p e ndent k in a s e but
inhib i ted b y pro t e in kinase C ( Pi tt ne r a nd fai n , 199 0 ) . In
contrast, d own r egUl ati o n of p rotein kina s e C sign ificant l y
en hanced the ma x i ma l phosphoinosi t icte respo nse du e t o
vaso pressin . Mauger e c ill. . (1985) sho....ed t h .,t i n ro t;
h e patocytes , cAMP- and Ca 2 ' -lin ked h o r mone s inc r ease
s yn e r g istic a lly the ce'" infl u x by activat ing t he sa me co'"
g a t ing s ys tem . I t ha s also bee n sugges t ed t hat g luc agon
facil itates the a ction o f va sopress i n on i ntrac e ll u lar ca'"
conc e n trat ion by a ccelera t i ng the re le as e of cal> [rom the
internal s tor e a nd po t e n t i ati ng t he vasopressi n-mediated ce ' "
influx (Comb e t te s er ,~ l . , 1986 ) . vasopressin and angiotens i n
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II also inh ibit the accumulation of cAMP in isolated
hepatocytes stimulated by qj ucaqon (Crane e t a 1 ., 1982 ;
Keppens a nd DeWulf, 1984 ) .
ROLE OF PROTEIN KIN1l,SE C
Phorbol esters are a series of tumour promoting compounds
which induct! a great variety of effects in different cells and
tissues. It has been shown that phorbol esters bind and
stimulate the ca 2+ _ activated phospholip id -dependent protein
k i naa e , known as p rotein kinase C (Castagna et: a1 . , 1982;
Kikkawa ee a1 . • 1983). The ability of phorbol esters, such as
PMA, to activate protein kinase (; (PK-C) direct ly, apparently
by replaci ng the requirement for diacylglycerol, has provided
a powerful tool to probe the actions of protein kinase C ( PK-
C) in t he i nt a c t cell. Activation of this kinase seems t o be
the major route whereby these tumour promoters exert their
actions .
Recently, it has become i ncreasingly apparent t hat PK-C
plays important role in altering the cel lular
responsiveness to a varie ty of agents; this change in
responsiveness seems to be associated with changes i n the
number, affini ty or state of phosphorylation of various
r ec e pt o r s and compo nents of signal transduction systems
(Hous lay, 1991) . The glucagon receptor was r e po r t ed to be
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ph os ph ory lated , as act i vat ion o f PK-C ca us es i t t o become
u nc oup led from G. unde r condition s whe r e i t ca n be c l e a rl y
s ho ...-: that G. does not become phos phoryl at ed ( Bus h fi cl d et.
al ., 19 90). Di ssociation between the cAMP co nc e nt r ations and
the met abol ic effects induced by glucagon is e v i de nced in the
pr e s e n c e o f ph orbol e ste r s (Garc ia-Sa inz ,,~ t al . , 1985) . PMA
dimi n i s h ed t he ac c umulati on of c AMP induced by gluca gon, but
had no s ignificant effect on the stimUlat i o n of ureagenesi s
produced by g l uca g on .
In the s tud i e s using ph orbol es te r s, as ac t i vators o f
p r o t e i n kina se C, however i t should be noted t hat t he
diacylg l y c erol p roduced i n the c ell may act ivate p r ote-in
kinase C isoforms selectively, depending up on the fatty a cid
composition of the diacylglycerol a nd that su ch a sp e c t r um and
mag nitude o f activ i ty may be very d ifferent from that achieved
by pho r bo l esters (Houslay, i 991 ) . Also, phorbol esters
achieve a prolonged activat ion o f protein kinase C and may
ca use i t s down -regulation (Ni sh izuka, 198 8).
PROBLEMS OF l:NVEBTIG1r.TION
The research in t his thesis can be d iv ided into t wo ma in
parts . The first pa rt i nve s t i g a t e s the r ole of g lucagon and
g lucagon-l ike peptides in the regulat i on of GCS, While the
second part d isc usses the signalling pathwa y (s) of g lucagon
"
st imu lat ion o f GCS.
Gl ucagon-related peptides such as GLP-l, oxyntomodulin and
gl icentin are becomi ng h ighly recognized for t he i r sequence
s imilarity with g l ucagon and the ir e f f ect s on the
physiologica l regu lation of many metabolic processes (Bloom
and Polak , 1982 ; Hol st e t ai. , 1987). The r e f o re , t he f irst
p art o f t hi s t hesis deals with t o.· · affe cts on t he flux
through GCS and on glycogeno l ysis . We found that oxyntomodulin
a nd glicent in stimula te t he flux t hrough the GC~ an d
glycoge nolys i s . Therefore, the question a ri s e s as to whether
gl ice nt in and oxyntomodul in are exerting these e ffects by
acting through the glucagon receptor. The glucagon receptor
antagon ists were used to exam ine this possibility .
As previously s tated , GCS is known t o be regulated by
glucagon . The major unanswered quest ion is h ow t he hormonal
s igna l is transmitted through the c yt op l a s m i nto the
mi tochondria and how does i t affect mitochondrial enzymes such
as GCS. In the s e c ond part o f t hi s t hesis this prob lem was
examined us i ng various cell agonists and antagonists tha t
affect certain pa rts of the signall ing pathway .
Phosphorylat ion! dephosphoryla tion processes play
i mporta n t roles in metabolic regulation . Therefore, The
involvement of phosphorylated proteins i n the r-equ La t. Lc n of
GCS was examined by using t he cytosolic protein phospha tase
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i nhibitor, ok ada i c acid . Okadaic acid ....as round t o raitdc
ho rmon a l ac t ion s on t he flux t hrough GCS which r a i s ed t he
qu est ion of pos s i b l e involvement or pho spho r ylat i on/
de phosphorylation p r oce sses i n t he glucagon stimulat ion o r t he
GCS . Th i s que s tion was a l s o e xaatnee i n cha pte r 4.
Since p r ote i n k ina s e A i s r e spon s ible fo r t he
pho sphoryl a tion o f man y c ytos o lic prote i ns, t he possibili~i' at
c AMP- i nd uc ed phos ph o rylat i on i n the regu l a tion or GCS was
examined usi ng the PK-A ago nist Sp - c AMPS a nd the PK- A
a ntagon ist Rp-8 -B r -cAM PS . The pos s ibl e i nv olveme nt o f cAMP-
d ependent p ho s phorylat i on in t he glucagon effect on GCS was
a l so e xamined .
The fact that glucago n, l i ke vasopress in an d a ngio t e ns i n
II , i s known to i ncrease Ca2• up t a ke i n rat hepa t ocytes
(Keppens et ai . , 1977) prompted us to investiga te t he r o l e o f
calci um i n the regul ation o f GCS; vaaopr-es s Ln an d an giotensi n
II a re kn own to ha ve no effec t on adenylyl cy clase act i v ity i n
the liver . In isolated. hepatocytes, the effec ts of vasopress i n
and a ng iotensin l I on t he g l yci ne cleava ge sy s t em we r e
exami ned. Phorbol est e rs have pr ov i d ed a powe rfu l t ool t o
i nv e s t i gate t he actions o f PI<- C i n the in t ac t cells. I n t hi s
s t ud y t he ph o rbol e s ter FHA has be en us ed t o ex a min e th e
question o f whether PI<-C i s i nv o l ved in the r-equ La t i cn of GCS






[l-14CJ glycine and omnifluor were obtained from DuPont New
England Nuclear (Mississauga, ontario) . Collagenase, CLS2, was
from Worthington Biochemical corporation (New Jersey, USA) .
GLP-l (7 -36) amide , oxyntomodulin (g l uc agon 37), glucagon (19-
29) , and Des -His1-Glu' -glucagon amide were from Sachem
(California, USA). sp - and Rp-B -Br-cl\MPS were purchased from
Biolog Life Science I ns t i t u t e , La Jolla, CA. Okadaic acid was
obtained from Biomo l Research Laboratories, Plymouth Meet ing,
PA. Glicentin was purchased from the American Pept ide Company,
Inc . Vasopressin a nd Angiotensin II , Phorbol 12-myristate U -
aceta te a nd Phorbol l2 -myristate i a-ececece 4-0-methyl ether
were from sigma (St. Louis, USA) . He xok i na s e and qfucose--u-
phosphate dehydrogenase were purchased from Boehringer
Mannheim Biochemica (Lava l , Que bec). Des -His1-Nle'-Alall-Ala l ' -
glucagon amide was a gif t from Dr . C. G. Uns on , The Rockefeller
University , New Yor k.
Anim a ls
Male Sprague-Dawley r ats (Charles River , Montreal )
weighing 300 -400 g were used for all s tud Iee . Rats were
allowed water and pu rina rat chow ad libi t um .
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METHODS
Prepa ra t i on of Jiepa t ocy tes
Hepatocytes were prepared as d escribed previously by Berry
01: a1 . , (1991 ) . Rats were anaesthetized with pentabarbitol 0.1
mIl 100 gm body weight . The femoral ve i n was ex posed and 0 .2
ml of s od i um heparin (100 0 USP Unitsl roL) was i nj e c t ed i n t o
it. The isolation of hepatocytes involved perfus ing rat liver
first with 50 0 ml of ca l cium-free Rrebs -Henseleit bicarbonate
medi um ( 24 roM NaHCO J , 1. 2 roM KH2PO" 1 .2 roM MgSO,.7H, O, 5 roM
KCI, 123 :mM NaCI) containing 2 roM EGTA, 20 mM glucose, 2 . 1 roM
lactate , and 0.3 roM pyruvate, gassed with 95 :5 02:C02 ' The flow
rate in all cases was appr.ox imately 40 mI l minute . This was
f ollowed by perfusing the liver with 500 ml of the same medium
which contained 1 .3 roM CaCI, and no EGTA. Calc ium -containing
xcens-Hense re Lt; medium containing lactate , pyruvate and
glucose with 0.25% bovine serum albumin ( Fr a c t i on V
essentially fatty acid free) and 50 mg collagenase/ lOa ml was
then recirculated for 15 to 20 minutes in a t otal volume of
100 mk ,
When the l i ve r started to l e a k it was removed and minced
in a petri dish . The suspension was then shaken i n a Oub no f f
metabolic shaker a t 370C with gassing 02:CO, (95:5) fo r 10
minutes . The r e s ul ting cells were spun down at 600 rpm for 2
minutes and washed twice more i n Krebs -Henseleit medium. The
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fi nal wash was in Krebs -He ns e leit medium containing 2. 5 \ eSA
and t he fina l suspension of c ells was a l s o i n t h i s medium.
Determinat i on at c ell quantity
Ce lls we re qu a nt ified by determi n ing their dry weight . A
J Illl al iquot of cell suspension was placed i n a metal wei gh i ng
pa n and a J 111 1 a liquo t o f t he !lnal r ee us pe n s Icn medium,
I<rebs-Hensele it medium co ntaini ng 2 . 51 BSA, wa s p l ac ed i n it
s e p a r a t e we igh ing pan . Both were dr i e d i n an ov e n a t 500C
ove r ni gh t . The di fference in weight between the ce l ls and the
medium was u s ed to determine the d ry wei g ht of the ce lls
present.
De t e rmi n a t ion o t cell viabili ty
The v iabili ty of the isolated cells was d e t ermined by
s taining wi t h 0 . 2\ t rypan b l ue in Krebs-Ringer pho spha t e . At
l e ast 200 c el l s we re c ounted using a neeeccyecee eer chambe r
a nd the pe rcentage o f cells s t a i ne d wi t h trypan b lue wa s
c a l c ula t ed . Thi s organic ami ne d ye is e xclud ed f rom
hepatocy tes wi t h intact memb ranes , whe reas damag ed ce lls
readily t ake i t up . Trypan blue i s nega t ive ly ch arged a nd it
s e e ms l i kely that the dy e is e xc luded a s a result of an
e ne rgy -dependent maintenance of a negative p lasma me mbr a ne
potential ins ide the hepatocyt es. Loss o f t hi s potential , due
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to cell injury, may allow trypan blue penetration (Berry et:
ai. , 1991). I n all experiments, the cell viability,
determi ned by trypan blue , was greater than 95 \ .
Preparat ion of mi tochondria
Mitochondria were isolated from livers of male Sprague-
Dawley rats as described previously by Jois et ai. , (1989) .
Rat s were k illed by cervical d i sloca t ion and the liver was
qu ickly removed. Then the l iver was homogenized , us i ng a
potter-Elve jhem hand-held homoge nizer , in an ice-cold medium
co ntaining 0.225 M mannitol, 0.075 M sucrose, 5 rnM HEPES, and
1 roM EGTA. The h omog e na t e was c en tr i f uge d for 10 minutes a t
600 xg and the superna tant was then centrifuged at 8200 xg for
10 mi nutes . The r esu lting pe llet was r e s us pen de d in the above
medium a nd c entrifuged at 8200 xg f or 10 minutes . The
resuspension an d centrifugation steps were repeated t wo times
a nd t he fi na l pel let was resuspended i n the same medium . The
respiratory control r a tio was d e t e r mi ned polarographically at
J OOC wi th 10 mM a - ke t og l ut a r a t e as substrate a nd was greate r
than 4 i n all cases . The incubation med i um co ntained 140 roM
KCl, 5 roM Tri s , 4 mM KHZP04 , 2 .5 mM MgCl z, and 1 . 5 roM EDTA an d
was adjusted t o pH 7 .4 . A s tandard b iuret proc edure was used
fo r de termining the p rotein concentrat ion of the mi tochondria l
suspe ns ion (Cornall e t ai ., 1949). Bovi ne serum a lbumin was
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used as a standard .
Mea surment o :f flux t hrough GCS i n i s olated hep a tocy tes
Determining fl ux through GCS was done by me asuring " co,
product ion from 0 .3 mM ( l - It c] q l yc i ne (Ha mpson 02' L _11 . , 19 83;
Jo is e r "11 . , 1989 ). Th i s concentration o f glycine was us e d as
it approximates that in the hepat ic portal blood ( Br os na n ,~ L
a 1 ., 19 83 ) . In cubat i ons were ca r ried out a t J 7°C, i n
triplicate, in a tota l volume o f 0 .5 mL of Krebs-Henseleit
medium co nt a i n i ng between 4-6 mg dry weight of hepatoc y tes.
Ce lls were preincubated in Krebs- He ns e lei t med ium f or 20 min
before the addition of (l_uC] glycine . Eac h flask was gassed
with 95:5 O:: CO: for 20 seconds afte r t he addit i on o f the
hepatocytes and also after t he add ition o f ( 1_14C] glycine . f or
zero time samples O. J ml of 30 % perch l oric a cid (w/ v) was
a dd ed before the hepatocytes . At the e nd o f the i nc uba t i on
per- Led the incubation f l as ks were equipped wi t h r ubbe r septa
i n which p lastic centre wells were suspended . NCS tissue
solubilizer was introduced into centre wells through the septa
just before termination et: i nc ubat i on with 0 .15 ml o f JO'l
(W/ V) perchloric acid . 14 COz wa s .c o l l ec t ed for 1 hour and the
centre wells were then t ra n s~rr"ed to s cintillation vials
containing 1 5 ml of s c i n t i lla tion fluid (Omni fluor ) .
Radioact ivity was determined in a liquid scintillation
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counter, with conve rsion t o dpm made usi ng an external
standard .
GCS flux in i solated mitochondri a
Isolated mitochondria were pre incubated in 25 ml
Er lenmeyer f l a s ks for 20 minutes at 3DOC before addition of
( l _u C) glycine. Al l I ncubat.Lcns we r e ca rried out in triplicate
a nd each flask c on tained 2-3 mg mitocho ndrial protein . The
i ncubation per-Led was t e rm i nated with the addition of 0 .3 ml
of 30% perchloric acid (wj v ). For zero time values the
perchloric acid wa s added before the mitochondria . Centre
wells containing NCS t i s s ue solubilizer were suspended i nside
t he incubation flasks t o t rap lICOZ released after termination
of i ncubation with 30% perc hl o r i c acid. "co, was co l l ec t ed for
60 minutes . The centre we l l s we r e then transfered to
scintillation v ials containing 15 ml of scintil lat ion fluid
(omnifluor ) a nd count ed .
valid i ty ot u sinq uC02 r elease f rom (~-uC] qlycine t o determi ne
the flux through GCS
Pr oduc t i on of 14C02 from [ I _He] g lycine by isolated
mitochon dria, i s o l a t ed pe r f us ed liver and isolated hepatocytes
has bee n s ho wn t o be predo mina nt l y due t o fl ux thr ough the GCS
enzyme system (Hampson et al. , 198.3; 1984 ; Jois ee 031., 198 9 ) .
53
Ha mp s on ee d l. , (198) me a s ur e d t he pr oduction o f "co, (rom
r r-v cj -. a nd [2 - uCl g lyc ine and the ("ha nge i n ox yge n
consumpt i on u po n the add i t ion o f glycine by lIi t oc hond ri a was
al so mea su red as a f u nction of g l ycine c on centra tion . The
cor r e l a t i on be tween the me asured mi t ochond r i a l ox yge n
c onsumpt i on due to glycine oxidat i on and t he ca l cul ate d , o r
"theoretical ," oxygen c onsumption based upon t he p roduc t i on o f
14C02 from [l·u CJ• a nd (2 _14C] glyc ine prove d t ha t ccs i s the
p redominant fate of t he added glycine . The y a lso demo nstrated
that addit i on of 1 m" sodium a rsenite a nd I mM aminooxyacet l c
ac id significant ly i nh i b i t e d the p roduct ion o f " c o, f r om [ 1-
uC]glycine . Arsenite poison t h i o l s a nd t here f ore i nhi b i ts t he
l i po a mi d e-d e pe nd e nt reaction o f glyc i ne cleava ge .
Ami n ooxy ac e t i c a cid is a pyridoxal pho spha te a ntagonist a nd
therefore , it woul d inhibit the GCS . Th ese expe r i ment s
indicated that the met a bo lic flux thr ough GCS ca n be moni tored
e ffectively, i n an i n t a c t and fully funct i onal mi t oc ho ndrial
sys t e m, by me a s ur i ng the p roduction of "CO2 from ( l _ lIC )
glycine . I n pe rfused r a t live r the prod uct i o n o f ..~ f rom ( 1-
14CJ_ and ( 2 _ HC] glycine was exa mined (Ha mps on €' C dl. , 198 4) .
At a glycine concentration of 10 mM, production of u C02 f rom
[1 -14CJ glyc i ne was maxima l, ex h ibiting a maximal act ivity o f
12 5 nmol of u C0 21 g/ mi n , com pa r ed t o pr oduc t i o n of 14C02 f r om
[2_14C] glycine which e xhib i ted a max imal activity of 40 nmol
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of HCOdg/ mi n . Washou t kinet ic expe r i ments , in pe rfused rat
l iver, with (l _HC] glycine ex hibi ted a single hal f-t i me of
"c o, d i s a ppe a r a nce , i ndicat i"g one metabolic poo l f r om which
"co, is derived (Hampson et al . , 1984 ) . I n isolated
he patocytes Jo1 s ee al . . ( 1989 ) de mons t r a ted t hat the
production o f " co, from (1 _ItC) glyc i ne was much highe r t han
that from [ 2_ 11C] g lycine a nd tha t the GCS Ls t he ma j or r oute
for glycine decarbo xyl a tion .
Glycogenol ysis i n isola ted h epatocytes
Glycoge no l ys is was de termined i n hepatocytes i s o l ated f r om
fed r a ts a s th e g lucose produced over the i nc uba t i on period .
I nc uba t i ons wer e done i n tripl i cate with a fi nal volume of 1
ml i n 25 ml Er lenmeyer fl a sks . Typ ica l i ncu ba t i on s cont ained
4-6 mg dry wt o f cells. The incu ba tions wer-e carr i ed out in
Kr eb s -Hen se l e it medium, qaa ae d with 95 :5 O~:COt a t J7 0C i n a
Oubnoff me t abo l ic s haker . Before the i nc ubat ion pe riod t he
ce l ls we re pr eincubated for 20 mi nu tes. The gluc o s e fo rmed
during this preincubat i on pe r i od was subtracted f r om the
g l uc o s e fo rme d duri ng the 30 minu t e incuba tion per i od . Af t e r
the 30 min u tes incubation pe riod 0.5 ml a liquots we r e r emove d
from t he flas ks i nt o Eppendo r f t ube s conta i n ing 50 ~l of 30 \
pe r chl oric ac id and c e ntri f uge d f or 2 minutes a t 12 , 00 0 x g .
The s upe r na t ant wa s neut r a li zed wi t h J M potassium phosphate
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(K3P04 ) and the gluc ose was assayed in the e uper na cant; usi ng
a s tandard e nzymatic q Luc os e-ee -ephoap ha t e dc hyd r cq e ne s e y
hexokinase method ( Be r gme ye r et .11 . , 19 7 .1) .
Attempts to i ncrease the sensitivity of the hepatoc yte s
At the begining of this research I examined a nu mbe r of
strategies that were expected to increase the sensitivi ty of
isol ated hepatocytes t o ho rmona l stimul at i on . These
experiments i nc luded : 1 ) Percol l treatment of hepatocytes. 2)
Reduction of the duration of i nc uba tions. 3) Reduc tion o f the
concentration of isolated hepatocytes i n the f i na l i ncubat ion
medium .
] -Removal of damaged bep a tocytes by treatment wi t h Perco ) 1
Percoll is a c ollo i d a l solutions which co ns is t s of
p ol yv i ny l pyrrolidine- coated c o llo i d al silica -gel pa rticles
(Per toft et al . , 1 9 7 7 ; 19 7 9 ) . I t forms an i s o-o smot ic g rad ient
within a density r a nge of 1-1. 3 gm/ml . The great advantage 01
Percoll comp ared with other gradient materi a l s, s uc h as
Metr i za mi de and Sod i um Met rizoate, i s its low c ont r ibution to
osmotic p ressure (Pertoft et .31. , 19 7 7) . High dens ity together
wi th i s o- os mol a l i t y , phys i o l og i c al ion i c strength and high
survival rate o f rat l iver c e l l s could on l y be ob t a i ned i n
Pe rcoll solut ions. Pertoft e t e l , , (1977) reported t ha t
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Percoll does no t impai r the gr owth and t he survival of t he rat
liver cell s . Smeds rod and Pertoft , (19 85) d emonstrated t h a t
Percoll centr ifugation is d rapid met ho d for mass isolation o f
fu nctionally i:1.tact he patocy t es an d r e ticuloendothe lial c e lls
from rat liver. Ul t r astructure a nalys i s shows that Percol l
d oes nat co n nect wi t h t h e cel l s during the sepa ration
p r o c edu r e . The use o f Pe r c oll as the g r adi e nt medium al l ows
g r ad i e nt formatio n an d cell sepa ration to t ake p l a ce
simul ta neously.
Fi r s t a Percoll i sotonic s o l u t i on was prepared from
Pe rcoll , bala nc ed s a l t solution and phosphate bu ffe r and the
pH was ad justed to 7 .4 wi th 0. 1 M He L The balanc ed sa l t
so lution was prepared by d i s s o l v i ng 80 g Nae l , 4g Kel a nd 2g
MgSO•. 7H20 in 11 H20 . A ph osphate buffe r was prepared
comprising 2. 4g Na2HPO. and 0 .4 9 KH2P04, dissolved i n 20 0 ml
H~O. Equ al vo l umes of cel l suspe ns ion an d Perco l l so lution
were add ed to 50 ml centrifuge t ubes . The y were mi xed gently
a nd c ent r ifuge d at c - as e a t 50 xg f o r 10 mi nute s . Cells
capable o f ex clud ing trypan b lue wi ll pellet, whereas da ma g ed
cel ls, non - parenchyma l cells, c ell agg r e ga t es a nd deb r is will
floa t i n t he upper r egion of ea ch t ube . To r emove the Percoll ,
the su pe rna tant wa s a spirated a n d t h e pel leted c ells were
resus pe n de d i n t he washing med ium and ce nt r ifug e d f or 3
minut es a t 40 xq . The wash ing s tep was repeated a nd the
pelleted ce l ls were resuspend ed i n Kre bs -He ns eleit med i um
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conta ing 2.5 % BSA (Berry er .'11., 199 1 ) .
The advantage of such a technique is t ha t i t only employs
l ow speed c entr ifuga tion s i n ce high s pe e d c e nt r ifuga tion
involv ing use of a Percoll grad ient h as been demo nstrated to
affect the sensi t ivity of i s o l a t ed hepatocytes . I t has bee n
repo r t ed tha t high s pee d centrifugation o f isolated
hepatocytes t hr ough a Pe r coll gradient impaired the abili ty of
insulin t o stimulate both the ox i dation of l abelled s ucc i nate
t o CO 2 and the incorporation of carbon atoms f r om this
compo und i nto protein ( Be r r y e c al., 19 9 1).
2 - Reductipn of the durat ion of i..w::J.l.la."~
The 20 minute pr e i ncu ba t i on pe riod was eliminated a nd the
hepa tocytes were i nc uba t ed direct ly with g l uc ag o n a nd I _I<C
gl yc i ne for 30 mi nu tes . The incubation was termi nated a nd UCO~
was c ollected as described earlier . The sensitivi t y of t he
hepatocytes to g lucagon stimulation was c ompa r ed wi th the
sens i tivity of hepatocytes t ha t were pre in cuba ted f o r 20
minutes be fore be i ng cha llenged with t he g lucagon . The
stimulat io n of t h e flux t hrough GCS and g lycogeno l ysis , dS a
f unc t i on of glucagon concentration, were t a ke n as a measure of
t he sensit ivity of the hepatocytes . The t wo sets of
hepatocytes were from t he same rat l i ve r and measureme nt of
the e f fect o f glucagon on GCS flux and glycogeno lysis was do ne
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s imultaneously , under t he same e xp e r i me nt a l c ondi tions .
3- Reduct jon o f the concentrat ion of the he c a t oc yt e s
After i so l ation of the hepatocytes they are r egularly
suspended 1: 18 i n Kr e bs - He ns ele i t medium cont ai ni ng 2. 5% 851..
I n o rde r to de t e r mi ne Whether conc e nt r a t i on of ce l ls a f fects
their response , an a liquot o f hepatocytes was d ilut ed 10 times
fu rther ( t o 1: 180) i n the same med ium. Their sensitivity to
s t imulation by glucagon, assessed as stimUlat i on o f GC5 flux
and glyc ogenolysis, was measured and compared to that of
hepatocytes Which were more con c ent r ated (1: 1 8 ) . Both sets of
hepatocytes were isolated f r om the s ame rat and were
preincubated for 20 mi nutes then i nc uba t ed for 30 minutes with
the glucagon and [ 1_HC} g lycine s imultaneously and unde r the
same c ondi tions .
statisti ca l analys is
Al l values were expressed as mean o f t hree sep a r a t e
experiments ± SO . Statistical analysis was done by student's
t test . MUlt iple compar isons were tested us i ng ANOVA and t he
TUkey multiple comparison test. A probabil ity, p < 0 . 05 , was
regarded as i ndicat ing s tatistical significance.
Ma x i ma l st imulat ion and half maximal stimu lation were
ca lcu lated using the computer program In p lot whi ch uses the
e qu a t i o n for a rectangUlar hyperbola
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'{ '" A • )( ! ( B + X)
This equation describes the bind ing of a ligand t o a
receptor as a f unct i on o f i ts c once n t ration . It is also known
as a saturation b indi ng curve or a b i nd i ng isothe rm. Y is t he
stimulation of GCS which i ncreases t o a p lateau value o f A
(max imal stimulation) . B is the dissociation c onstant (hal f
maximal stimulation). Maxi ma l stimulation (A ) i s expressed as
nmoles! )0 minI mg d ry wt ; Half maximal stimulation ( B) is
exp ressed as Mola r co ncentr a tion . I n some experiments i n which
very h i gh glucag on concentrations began t o i nhib it the GCS
fl4 X only those conc e nt r a t i ons wh ich were s t imulatory were
used . It is recogni zed that the ph en omena ob served in t h i s
work a r e more comprex t han simple l i ga nd b inding but are well
described by thi s equation as in dicated by r 2 values of more





The GCS enzyme system is known to be regulated by
glucogenic ho rmones such as g lucagon (Jois et 31 . , 1989:
Brosnan e s: al. , 1990) . Glucagon-related peptides such a s
oxyntomoduli n , glicentin and GLP-l (7 -36) amide share sequence
simi larity w i t h glucagon and also p lay im portan t regulatory
roles. Therefore, we decided t o study their e ffect on the flux
through GCS . The effect of glucagon (19 -29) on t h e flux
through GCS was a lso examined . In addition, glucagon receptor
antagonists were u sed to determine whether t he 9 1ucagon -
re la ted peptides were able to affect GCS flux an d
g lycogenolysis via interaction with the g lucagon receptor.
ATTEMPT B TO I NCREA S E 'l'HE SENS:I 'l'I VI T Y OF ISOLATED HEPAT OCYTES
Gl ucagon stimulates the flux through GCS an d
glycogenol ys is in i s ol a ted rat hepatocytes wi t h a half maxima l
stimUlation which occurs at g lucago n concentra t ions of 4 .3 ±
1.3 n M and 3.3 ± 0.8 nM, respectively (Fig. 3.1 ). Three
diffe r ent a pproa c hs we re examined at t he beg i ning o f this
resea rch project in a n effort to increase t he sensit ivity o f
th e isolate d he patocyte s to glucagon sti mUlation . The se
experiments i ncluded :
1 ) Percell treatment of isola ted h epa t ecyt e s . 2) Re ducing
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Fig . 3 . 1 s timulation o f t he flux through Ges and
glycogenolysis by gl uc a go n i n i so l a t ed r a t hep a tocytes
The basa l rate for GCS flux was L 3 ± 0.9 nmoiesl )0 minI mg
dry wt. and for g lycogenolysis vas 176 ± 33 nllloies/ 30 min i mq
dry wt. Results are e xpr e s s ed as the percentage of th e
unstimulated r ate f o r both GCS flu): and glycogenolysis .
Resu l t s are mea n s of three sepll.rate exper i ments ± SO.
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Fig . 3.1

















80 /,"<'-'-_ -1._ --'-_ --'-_ --'-_ --'-_ -'
a -10 -9 -8 -7 ·6
LOG MOLAR(G L UCAGO N]
______ FL UX THROU GH GCS
65
- .- GL VCOGENOLYSIS
the duratio n of incubat ions . 3) Decreasing the concene ro t Lcn
of t h e hepa ti ocyt e a in t h e final incubation volume.
Perco~l t re a tment of i solat ed hepato cyt e s
Glucagon stimulat ion o f t h e fl ux t h r o ugh GCS and
glycogenolysis was measured in isolated h e pat oc y t es p r e pa r e d
r egularl y a nd i n Perco l l pu rified isola t ed hepatoc ytes . No
significant diffe rence was detected i n the h a lf maximal
stimulation or i n the ma x i mal stimulation of ItC OJ or glucose
produ c t i on as shown i n t a bl e 3.1 .
Reduct i on of t he duration of i ncuba tion
The sens i t ivity of isolated he p a t oc yt e s that were
p r e incubat ed for 20 minu tes before t he incubation was compa red
t o anothe r group wi t h out t he pre i nCub at i on per L od , No
sign i ficant diffe rence was f o und i n half maxi ma l stimulation
or maxi mal stimulation of GCS f lux o r glycogenolysis by
glucag on betwe e n both groups (table 3.2 ) •
Decreas i ng- t he concentration of hepatocyt es i n the fi nal
i ncubati on vo lume
Iso l at ed hepatocytes that were regularl y s uspended l: l B in
Kr ebs- Hense l e i t medi um co nt a i ning 2 .5% BS A did not show any
signi f icant d i fference in the i r respons e to glucagon
stimUlation, as measured by t he flux t hrough GCS a n d
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Ta b le J .1 Effect of Percoll purification ot i solated
hepatocytes on their sensitivity to glucaqon stimulation of
the flux through GCB and glycogenolysis
Fl \l>C thl'ough GCS GIycogeno~ysis
Hal t Max imum GCS Hal t MaximJm gluccose__1
t lwt r ate _1 prodllction eee e
s t i rml a t i on (nrroole s!30Illin s tilmJlation (nIIICIles!30 ITlin
''''''
!rrqd~ wt . l
''''''
!lI'q dl' y vt ,)
Wi th Pe rcoll 3. 6± 0. ' 3 .9± 0. ' a .a e e.a
'"
...
Wi t hout Pel'coll 3 . 3± 0 .' 3 .9 ± 1. 1 3 .3t 1 .0 no .aa
Both GCS and g lycogeno l ysis were measured. Bot h groups were
compa red 1\sing paired t-t est , p > 0 .05 . Basal r ate of GCS flux
i s 1. 5 2 :!: 0 .89 nmoles/ JOm in/ mg d ry wt • Basal r at e of
g lycogenolysis is 184.4 ± 22 nmol e s / 30 mi n/ mg dry wt.
Results are means from t h r ee separate experiments ± SD.
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Tab 1 e 3.2 Effect of p reincu bation of hep atocytes o n the ir
s e n s i tivi t y t o qlueaqon s t i mu lat i o n of t be fl u x t hrouqb GCS
and q1yeoqeno1ysls
,,~ throuqh ces C:1y c:o q l no l y. , s
Halt Max.iJnwII GCS Mdt Mui_ q l uc;o • •
......, f l."""" ute m&>(illld prod~ctioft r a t ..
IUmubtio n (1\IrlO 1."s!30ndn 'timu h .tion (l\IIIO l. ... !30nU. n
I~l Inq d.ry IIt .1 '~l
''''
dry IIt .1
Pr.:lnccl>at:loft 3 .3t O.6 ' . 3 1:1 .0 ,..t o .9 3 •• t> .




Bas a l ra t e fo r GCS i s 1. 7 ~ 0 . 9 and for ql ucosc pr oducti on is
198 ± 40 nmol es / 30 lIIin / 119 dry wt . Both q r oups wer e c ampa red
us i n g pa ire d t - tes t , p > 0 . 0 5 . Results are mean s f r o m t h r e e
se pa r at e e xperi men t s .t SD.
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glycogenolysis, when compared to isolated hepatocytes that
were suspended 1:180 in the same medium. Half max imal
stimulation and maximal stimulat ion of GCS flux and
glycogenolysis did not differ significantly (Table 3 .3).
Since we were unable to increase the sensitivity of
i s o l a t ed h e pa t oc y t es to glucagon by these means we p roceeded
with our exper iments with regularly isolated hepatocytes,
preincubated for 20 min utes a nd then incubated fo r 30 minutes
at a concentration of about 8 -12 mg cellsl mI .
EFFECT OF GLtlCAGON~RELATED PEP'l'IDES ON GCS FLUX
The first quesrt Ion that was examined was whether g1uca9on -
related peptides such as oxy'nt.omo'duj Ln, glicentin a nd GLP-l
(7 - 3 6 ) amide stimulate the flux th rough GCS in the isolated
hepatocytes . When incubated with isolated hepatocytes,
oxy ntomodulin and glicentin stimulated the flux through GCS a t
high co ncentration of 1 J,lM and 0 .1 J.lM, respect ively (F ig .
3.2). The maximum stimulation obtained with oxyntomodulin was
about 100 % at a concentration o f 10 t.lM of the p eptide.
Nean wh.i Ie , the maximum stimulation obta ined with glicentin was
abou t 60% at a concentration of 1 lA M glicentin . Similar
res ul t s ob tained with glycogenolysis for both
oxyntomodulin and glicentin (Fig. 3.3 ) .
69
Table 3 . J Effect o f hepatocyte c oncentration on their
s e ns i tivity to g l uc agon s timu l a t i o n of GCS fl ux and
g lycogenolysi s
Fl ux t h r ou g h GCS Gl yo::oq.. no l y s i "
Half max imal MaximUm GCS Half ll\A>li m&1 Ma.ximwn q l u <;o ...
stifmJh.tion f l m< rat@ "ti ...,lat i o n p "odue tioo r at..
'''"'
(nmo l e " / 3 0 mj, n ,"", (nmo lu/ 3 0 mln
l IN:}dry .. t . ) / rrq d r y wt . 1
1 :18 5 .21:1.9 2 .11: 0 . '7 5 . 3 t 0 .9 2n 1: 23
d ilution
l : U O 5 .31:0 .9 '.1 1:0 .9 4 . 4 1:1. 3 ~ 90 t a a
di l u t i on
Basal rate of GCS f l ux i s 1.02 ± 0.93 nmoles l ]0 min i mg dry
wt • Basal rate of glycogenolysis i s 1 5 6 ± ) 4 . 8 nmca esz r o mi ni
mg dry wt; • Results are the me a n s o f three sep a ra t e
experiments . s t ude nt ' s t - test was used to compare half mex Imel
st imul a tion a nd maxima l rate of GCS a nd glucose produc t ion for
bo th grou ps . No s ignificant difference was detected, p ;, 0 .0 5 .
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Fiqu r e 3 . 2 stimu lation o f t he flux thrcauqb GCS b y
o xyn tomod ulin a nd q U c en t i n in i s ola teeS r a t hepatocytes
Different prepanlt ions of isolated hepatocytes
pre incubated fo r 20 e t n ue e s before t he y we re incubat ed wi t h
0.3 mM r-vc glycine and oxyntomoduli n or gl icentin for 30
min utes . Results are e xpre s sed as the perce n t a g e of the
un st i mulat ed r ate . The basal r a t e s for GCS fl ux a re 1.2 ± 0 . 1
a nd 2 .4 ± 0 . 6 nmoles/ 30 mi ni rng d ry wt • f o r o xy n t omodulin an d
glic e nt i n , res pec t ively . Re su l t s are the means o f th r e e
di ff e r e n t experime nt s ± s o .
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Fig . 3.2
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Figure 1 .1 oxyntomodulin and glicentin stimulation ot
glycog e n o lysis i n i s o l a t e d rat hepatocytes
Hepatocytes were pre incuba t ed for 20 minutes before the
add ition of oxyntomodulin or glicenti n . The ba s al r a t e s were
105 :!: 10 a nd 18 3 ± 1) nmol e s g luc o s e / 30 minI mg d ry v e • t o r
ox yn tomo d u lin a nd glicent in, respe ct.i vel y . Resu l t s are means
:!: S O; n = 3 .
13
Fig. 3.3
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- • ..- OXYNTOMODULIN
GI..P-l (7 -36) amide was found to be wi t hout effect on the
GCS or glycogenolysis i n isolated rat hepatocytes as shown in
t able 3 . 4 . The pe ptide wa s without ef fect on t he un stimulated
b a s al r ate of the re lease of 14 C02 or glucose produ ct ion a s
we l l. Whe n pre i ncubated with iso l a ted h e pa t ocyte s b e f ore t he y
were ch allenged with gl uc ag on , i t was found t hat GLP-l (7 -36)
a mide h a d no effect on the glucago n s t i mulation of the fl ux
throug h GCS (Fig. 3.4) o r g lycogenolysis (F i g. 3.5) .
The question o f a possible r ole of glucagon ( 19 -29 ) , which
i s also known as rni n iglucagon, on t he met a b o l i c proce sse s in
t he l iver was invest igat ed by ex a mining i ts e f f ec t on t he fl ux
t hrough GCS and g l ycogeno lys i s . I n c ubati on of i so l a t ed
he pa t ocytes wi t h miniglucagon had n o effec t on the fl ux
t hr ou gh GCS or glycog eno lysis( Fig. 3 .6 ) .
I s the stimu l a tio n o f GCS by glice n ti n and oxynt omodu!in
brought ab out v i a i n t er a.c ti on with the gl uca gon receptor?
Glucago n recep tor antagonis ts were us e d to examine th is
qu estion. Another questi on whi ch co ul d be cons i de r ed here i s
whether bepee.cc ye e e possess two dist inct rece ptors f or
g l uc a go n or j ust o ne receptor t ha t l e ads t o two diffe r e nt
s ig na l s . I n a ll t h e e xperiments t ha t we re d o ne wi th rec eptor
an tagon ists glycogenolysis was measu red s o as t o compare their
7 5
Table 3 ." Effect ot' GLP-l (7-36) ami de on the flux through
GCS and glycoge nolysi s i n i solated rat h e p a t oc y t es
Flux through GCS Glycogenolysis
(nmo l.s/30nd n ! nq dry v l: . ) t nmo l .. s ! 30nd n! "'9 dry v t . )
Ba sal r ate 2 .07 ± 0 . 6 8 1S 7 ± J5
lO -IM GLP-l 2. 11 + 0 . 9 8 19G ± 45
Lsc Lat.ed hepa tocytes were preincubat ed with GLP-l (7- 36) amide
fo r 20 minutes before the reaction wa s i n i t i ated by the
add Lti Lc n of i-v c glyc ine . "co, was c o llected and coun t e d a nd
qj.ycoqenol.ya Ls was measured . Results a re means ± SO, n=J . Both
g r ou ps were compared using paired t-test , p ;> 0 . 05 .
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Figu r e 3 .4 Ef f ec t of GLP- l ( 7 - 36 ) ami de o n g l u o a go n-
st im u l at e d flux through GCS in iso lated hepatocyte s
Iso lated he pa t oc ytes were pr-eincubated for 20 minutes without
(e) and with ( _j c;LP-! (7 - 36 ) amide befo r e they were
challenged with g luc ag o n . Half maxima l stimulation of the flux
through GCS oc c u r r-e d at ( e ) 3.1 ± 0 .9 VS . (_) 3 .4 ± 0 . 4 nM
glucagon concentrat ion (p ;. 0. 05, Paired t -test). aesures are
means ot f our d i f f e r e n t experiments ± SD.
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Fig. 3.4
EFFECT OF GLP- 1 ON GLUCAGON -STIMULATED GCS
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F i gu r e l .S Ef f e c t of GLP- l (7 - 3 6) ami de on g l uc a go n -
s timu l a t e d g l ycog e no l y sis i n i sol a t e d hepato c yte s
A g lucagon dose r espo ns e c urve for glycogenolysis was done (_)
with and without ( e ) the presence o f 100 nM GLP-l (7 -3 6 )
amide . Hal f max ima l stimulat i on of the glucagon c urve o ccur r e d
at ( _) 2.3 ± 0 . 6 nM vs . ( e ) 2 . 6 ± 0 .5 nM g l ucagon
concentrat ion (p > 0 . 05, pa ired t - t est). Results are expressed
as t h e percentage of the unst imulated basa l rate . Resu lts a re
cnc means o f four di ffe rent exper i ments ± SD.
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Fig . 3.5
EFFEC T OF GLP -1 ON GLU CAGON-STIMULATED
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Fig. 3. 6 Ef f e c t o f mi niql uc agon on the nux through GCS a nd
glycogenolysis i n i s ola t ed r a t he patocytes
Isolated h e p a tocytes were p r e i n c ubated for 20 mi nu tes , t hen
rnev ver e i nc u bated with miniglucagon a nd 0 .3 mM I _HC glyc i ne
for 30 mi nutes . Results a r e expressed as t h e p r ecen tage of the
unst imu l ated ba sal r a t e . The ba s al r ates a r e 1 . 5 ± 0. 6 nmol eay
30 mini mg dry wt . f or GCS flu x and 1 0 7 ± 15 nmole s glucose/
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e f f ec t s on the glucag on- induc ed s timula t io n o f glycogenolysis
( I"epr es en tinq a cytoplasmic process) a nd t h e flux t h r ough GCS
( rep r esenting a rlli tochondr i a l process).
pr-e Lnc ube t.Lcn of t he hepatocytes wi t h va rious
co ncent rations of t he g lucagon recept o r -antagonist d es-His1-
Clu' - g l ucagon 811lide was do ne before hepatocytes were
cha lle ng ed with g lucagon, g l i centin, o r oxyntom odul in. A
sign ifi c a nt inh i bi t i on o f a bou t 40 \ o f t he s timul a t o I"y e f fec t
o f g l uc agon (Fig. 3.7 ), oxynt omodul1n (F i g. 3 . 8 ) and glicent in
(Fig . 3 .9) o n t he flux t hroug h GCS a nd glycogenolys i s wa s
f ound . I t was not po s s ible to a ttempt h ighe r c oncentrat ions of
th i s a n tagon ist d ue t o its expen s e .
Fig . 3. 10 s hows that t he st i mUlat ory effec t of glucagon on
the flux t hrough CCS a nd glyc ogenol y s i s was inhibited by 80\
whe n t he hepa t ocy t e s were p re incubated wi t h 1 0 11K d es-His1-
Nle'- Al aH - Ala"-glucagon amide , . before they wer e chal l en ged
with glu ca gon .
.3
Fi g. 3 .7 I nh ibit i on o f g luc ag on-stimu l a ted flux throug h GCS
a nd g l y cog e no l y s i s by d e s - Hi s 1- GI U "- g l uca o;ron amide
Flux through GCS and glycogenolysis were determined in
isolated rat hepatocytes . Th e a ntagonist was pt-e i ncuba t e d wi t h
t he hepatocytes f or 2 0 minutes before t hey were cha Lj cnqcd
with 10 nM qkucaqcn , uCO~ and g lucose production during the ]0
minutes incubation period was determined . Contro l Lncutat Icns
were made w3.~h the a ntagonist alone to dete rmi ne I f it had an
effect on th" basal rate of GCS flux or g lucose pr-oduct Ion ,
The b a s a l rate for GCS flux is 1.4 t 0 .5 nmoles/ 30 mi ni mq
dry we . and fc r- g lucose production is 95 ± B.6 nmo l e s / 30 mi ni
mg dry wt. (*p c 0.05 VS. control with no a nt a g o n i s t ) . Resu lts
are mea ns ± SO, n '"' J .
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Fig. 3.9 Inhibition of oxyntomodulin s timu l a t e d fl ux through
GCB and glycogenolysi s by de s-His1-Glu9-glucaqon amide in
i s olate hepatocytes
Isolated rat hepatocytes were pre incubated with the antagonist
for 20 mi nutes before the react ion was initiated by the
addition of 10- 5 M oxyntomodulin and 0 .3 mM a-ve glycine. Flux
through GC5 and glycogenolys i s were measured. Contro l
i nc u bat i ons with the antagonist a lone for both GCS flux and
Qlycogenolysis were carried out . The basal r a t e for the flux
through GCS is 1.9 ± 0 .2 nmol e s / 3 0 mini mg dry wt. The basal
rate for glucose prc Ju ction is lOS ± 10 nmoLeay 3 0 mini mg dry
wt. ( * p < 0.05 vs . control w>ith no an tagonist) . Res ults a re
means ± so of t hree separate experiments.
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Fi g . 3 . 9 Inhibition of glicentin stimula tion o f t he flux
through GCS and g lycog e nolys is by des-Hi ll : - G lu~-g lucagon amide
Dcs -His1-Glu9-glucagon amide was pr e i nc uba t ed wi th the i s o l a t ed
cells a t 370C before the addit io n of I _H C glyc ine and 10-5 M
glicentin a t t he begining of the i nc uba t ion period. Results
are expressed as pe rcentage o f the unstimulated basal rate .
The basa l rates are 1. 4 ± 0 .1 a nd 1 36 ± 38 nmoLea y 30 mini mg
dry wt . f or GCS flux and glycogenolysis, respectively . Res ults
are t he means of t h ree s eparate experiments ± s o. * p < 0. 05
vs . contro l with n o antagon ist; by ANOVA .
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F i g. 3.10 Inhibition o f g lucagon s t i mul a t i on o f the flux
through GCS a nd g lycog e nolys is by de s-His1-Nle "-Ala::-Alau
g l uca gon amide
1'I C02 and glucose production was measured t o dete rmi ne the f l ux
t hrough GCS and g lycogenolysis in isolated he pa t ocyte s . The
a ntagonist was pre i nc uba ted with the cell s for 20 min ute s
before adding glucagon and a -ve g lycine . GCS fl ux and
g l ycogeno l ys i s wer e mea sured a s nmoles o f 14 C02 o r gluco s e
produced/ 30 mi nI mg d r y wt a nd we r e e xpresse d as pe rcen t ag e
of t he unstimulated rate. The basal rate s a rGl 2.6 ± 0 .8
nmc l esy 30 minI mg dry wt • for GCS flu x and 1 14 ± 9 . 6 nmol es /
30 mi nI mg dry wt • for gl ycogenolysis . Results a re means ± SD,
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DI SC USSION
The sens itiv i ty o f he pa t oc y tes to g luca go n a r e different
i n d iffe re nt experimental systems . The sensi t ivi t y of isolated
hepatoc ytes i n ba t c h incu ba t i on to g l uca go n stimulat i on has
been re ported t o be les s t ha n that of peri fused hepatocytes or
t he perfused l i ve r at the same c onc e nt ration o f g luc agon a s
mea s u r ed by s t imulat ion o f g lycogenolys i s (Hine e r a1. , 1990).
Ha lf max ima l s t imulation o f g lycoge no lys is in isol a t ed r at
hep a t ocyt e s occur red at 10-' M g l uc a go n compa r ed to 9XlO·11 M
a nd 5XlO-11 M in pe ri fused he patocyte s a nd perfused live r ,
r espe ct i ve l y. Severa l mecha nisms hav e be en s ugg e s t e d fo r tha t
differe nc e i n the sens i t i v i ty to g luc a gon s timulat ion . The
fi r s t pos s i bi lity is t hat hepat oc ytes a re pa r t i all y dama ge d
d ur ing t he i s olat i o n so t h ey on l y res po nd t o hig h
c oncentrations of g l uc ago n . acvever , t he sensitiv i ty of t he
sallie i s ol ated he patocy t e s t o glucagon i nc r ea s e s ....hen cells a re
s timula t ed i n flow-throug h pe ri f us i on system. Th e second
pos s ib i lity is t ha t g lucagon is d eg r a ded in t he batch
i ncu ba t ion system : howe ver . addition o f ag en ts that inhibi t
de g r a dat ion o f glucagon t o t he batc h i nc u bat i o n ee d I ua
co nc omita ntly wi t h gluc a gon had n o eff ect on t he gl ucose
o ut pu t i n response t o g l uc ag on (Hi ne at a1., 19 9 0 ) . Th ey
s ugge s t ed the exist e nce o f a n inhi bitory s ubs t a nce (s ) secreted
f r om gluc ago n- stimul ated he pa t ocyte s whi ch may account for the
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insensit i vty of hepatocytes to g lucagon observe d i n a batch
i ncuba tion system .
The three dif ferent e xperimen tal ap p r oachs which were
examined i n th is t he s i s we r e not able to increase the
sensitivity of the isolated he patocytes to glucagon
s timulat ion . In our s ystem, glucagon st i mul ate s the flux
through GCS an d glycog e nolysis with a half maximal stimulation
at 4 . 35 ± 1. 32 nM a nd 3 . 38 ± 0 .83 nM glucagon , r e s pec tive ly.
Th is is s imi l ar to that ob tained by Mi ne et al . , (1990 ) and
corvera et al . , (1984) . We f i nd t ha t the sensitivity cannot be
readi ly i nc r e a s e d i n a ny of t he ways described earl ier .
I n t he present study , the effect of g lucago n-rolated
pe p t i de s , ox yn tom odul i n , gl icentin, and GLP-l o n t he flux
thr ough GCS and glycoge nolysi s were examined . Res ults s hown in
Fig . 3 .2 an d Fi g . 3 .3 c l early show that the flux t hrou gh GCS
a nd glycogeno lysis a r e s timulated by oxy ntomoduli n a nd
gl icentin . This is c ons i stent with the r esul ts reported by
Kervran e c al . , (1 990 ) who f ound that, in vivo , oxy ntomoduli n
disp l ays a hype r g l yc emic effect a t a dose 10 t i me s higher than
the dose of g l uc agon r equ ired t o produce the sa me e ffect . In
vi t r o , i n i s o l ated hepatocytes oxyn tomodu l i n stimulated
l)lyco ge no lys i s but r equired a muc h h i ghe r dos e t h an did
glucagon (Kojima et al. , 1988) . Although t he co nc entrations of
oxyntomodul i n a nd glicentin t ha t were used in our e xperiment.s
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were very high, the involvement of these peptides in
regulating the flux through GC~ and glycogenolysis might occur
in pathological cases .
Table 3 .4 shows no effect of GLP-l (7 -36) amide on the
flux through GCS or on glycogenolysis . This is consistent with
the results of Blackmore et ai., (1991) They showed that GLP-l
(7 - 37) , which has a similar action to GLP- 1 (7-36) amide, does
not stimulate h epa t i c glycogenolysis (as measured by
phosphorylase activat ion) or gluconeogenesis (measured by the
conversion of "c-Laccate to Hc-glucose) in rats . Fig . 3 .4 and
Fig. 3 .5 also show no effect of GLP- l (7 -36 ) amide on the
glucagon stimulation of GCS flux and g lycogenolysis . specific
binding sites for the amidated peptides, which do not show
binding to insulin or glucagon, in hepatocyte plasma membranes
was r epor t e d by Villanueva·Pencarrillo et al . , ( 1993) . I n
addition, it has been reported that GLP-l (7 -37) does not
displace glucagon from its receptor(s) on the hepatic plasma
membrane (Ghigl ione et al., 1985 ) . These results are
consis tent with the absence of '~ffect of GLP- I on glucagon
stimulat ion of GCS and glycogenolysis . Valverde et al . , (1994)
r-epcr-t.ed that lO-'M GLP-l r educ ed t he cAMP content of glucagon-
stimUlated hepatocytes on ly in the absence of 3-isobutyl-1-
methyxanthine ( I BMX) , a nonspecific cAMP phosphodiesterase
inhibi tor , which indicates that GLP-l may stimulate a cAMP
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phosph od ieste rase activ ity . Howev er , as wil l be d i s cus sed i n
ch apter t! , PKA a nd cAMP a re no t the only factors involved i n
t he regulation o f GCS by glucagon .
Fig . 3 .6 show s no effect o f min iglucagon on the flu x
th ro ugh GCS and g lycogeno lysis a t a ny concentration t ested .
Ma lla t e c al. , (1987) r eported t hat bo t h minig lucago n a nd
g lucago n (18 -29) have no effect on hep at ic ad en yly l c yclase
activity. Howeve r our re a s on fo r examini ng minigl ucagon lay in
its p os s i b l e i nh i bit i on of the calcium pump with a possible
increase i n intrace llular calc i um. Witho ut measurements of
intracellular calcium, we can make no further comments o n t he
lack o f e ffect o f mi niglucagon .
De s - His1- Gl u ll -g l uca gon amid e whi c h is known t o be a po t e nt
antagonist of the glucagon recepto r i nhib i t ed t he s t i mu l ation
of f lux t hrou gh GCS a nd glyc ogenolysis by g lucagon,
ox y ntomodu l i n a nd gl icent i n . .These reeut cs s uggest tha t
oxyntomodulin and glicentin a r e e xe rt in g their effects t hroug h
the i r binding t o gluc ago n recept or (s) i n liver p l as m"
membrane .
It has been s uggested that hep atocytes possess tw o
d i stinct r e ceptors for g lucago n : a GR- 1 receptor c ou pled to
s t i mu l a t ion o f i nos i tol phospholipid b r ea kdo wn and a GR-2
re ceptor co upled t o s timul a t i on o f adenyla t e cycla s e activ i t y
(Wake lam et al., 1986). It i s c onceivable , t here fore , t h a t
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g lycogenolysis and glycine catabolism could be stimulated via
s eparate glucagon receptors. I f this wer-e the case o ne would
expect them to disp lay differential sensitivity to glucagon
receptor a ntagonists. The resul ts s hown i n Fig. J . 7 show t hat
t h i s was not the case since GCS flux and glycogenolysis were
equally i nhibited a t the same concentration of t he a ntagonist .
These results we r e co nf irmed again by usi ng a more potent
glucagon r eceptor antago nist des-His l - Nle 9 -Ala ll-AJ aU-glucagon
amide as shown i n Fig. 3.10. These results cannot a nswe r our
quest ion, howev e r , because t he r e two possible
explanations. The first pos sibilit y is the presence of two
d i f f e rent g l uc agon r eceptor s to wh i ch the g l uca gon recepto r
an tago nis ts bind wi th the same affinity. The s ec ond possible
e :.<p lanation would be tha t t he re is on l y o ne receptor but two
different G prote i ns, and i t i s their r elativ e activa tion by
the hor mone - r ecep t or complex that i s diffe r ent and is
r e sponsible for t he difference i n the re l ease of the t wo
messengers in r esponse t o t he a nalogue. Thi s is co ns istent
wi t h the r e s ults re po r ted by J eline k et al. , (1 993) ......ho
iso l a t ed a complementary DNA c lone fo r the g l uc agon rec ep tor
and p roved t hat i t binds glucagon a nd t r ansduces s i gnals t hat




Al th ou gh t h e st Imu j a t rcn of GCS fl u x by g l u c ag o n has been
u o mo ns t r e tec previously , it Is no t kn own how the hormona l
5 i q na l Lc t r ;ln smi tted fro m t he q Luce qcn receptors o n 1 t v e r
pl asma membrane through the cytoplasm to t he mitochondria.
Th i s pro b l e m was examined using d i f f e r e n t agents that affect
different parts of the s i g nal l i ng pathway .
Protein pho sp horylation a nd fl ux through GCS
The poas i b i Li ty of i nvo l ve me n t of p hosphorylated proteins
wa s examined us ing okadaic acid which i s a potent cel l -
pe rmeable i nh i b i t o r o f t h e c ytop las mi c protein phosphatases
['PI and PP2A ( Cohen and Cohe n, 1989) . Okadaic a cid stiinula ted
the fl u x t hrough GCS a nd glycogenolysis i n i s ol a t e d
hepatoc y tes (Fig . 4 . 1 ) . The maxima l e f fe c t was found at 1 JlH
okadaic a c id. A control experiment s howed t hat okadaic a cid
h a d no d i r e c t effec t on GCS i n isolated mitochondria {Ta b l e
4. 1) . This sug gest s tha t t h e s t im ulation fou nd in i so l a t ed
hepatocy tes i s due ':0 t h e wel l est ablished inh i bit ion of
cy tosol1c protein phosphatases and inc rea s e in the
concen tration of phospho rylated p roteins , rathe r t han a d i r ect
e ffec t at th e l e ve l of the mitochondria .
A g l u c ag o n dose -response c u r v e for the flux t h r oug h GCS
was do ne i n the presence o f a submaxima l concen tra tion o f
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Fiq. 4 .1 Ef f ec t o f olt a d a ie acid o n the flux t hrouq h GCS an d
g l yco g eno l y si s
Okadaic acid was added to the hepatocytes at the st.,rt of ,1 ~O
minute preincubati o n at 37<lC. af t e r whi ch the y we re incubated
wi t h 0.3 mM I _II C glycine f or 30 minu tes. Th e r l ux t hrough GCS
wa s me asured b y the nec i ee o f I 'CO~ r e lease d/ 30 mi n! mq dry
we. Be f o r e the reaction vas terminated ali q uots we r e removod
from the i nc u ba t i on flasks to de te rmi ne the amount or g l ucos e
produced as nmol e s l 30 mini mg dry wt . The bas a l ra t e (or GCS
flux is 1, 1 :!: 0 .3 nmo Lesy 30 mini mq dry wt . a n d f o r
g lycogen olys i s is 235 :t 38 nmo l e s ! 30 mini mq dry wt • n e su t c s
are means ± S O; n "" J.
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Table -4.1 Ef f e c t of okadaic acid on the fl ux through GCS in
i solated mitochondr ia
Flux thr ough GCS




Control, DHSO 0.16 + 0 . 02
okadaic ac id, ,'- 0 .17 ± 0.0 3
I s o l ated mitochondria wer e p r e i nc u bat ed at JOoC f or 2 0 mi nutes
wi t h 1 ~M okad a ic ac id a nd DMSO as a c ontrol si nc e oxa o a Ic
ac id is prepa r e d in DMSO. Then t hey wer e i ncub a t ed with 0 .3 mM
l _14C glycine f o r 20 mi nut e s and the reacti on was stopped with
the addi tion of 0.3 ml of 30% peA and 14C02 was col l ec t ed f or
an h our . The amoun t o f 11002 released was used to dete r mine the
flux through GCS, calculated as n mol es of HCOd mg
mi tochon drial prote i n I mi n . Results are means of t hree
separate experiments ± SD.
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okadaic acid (0.01 /.1M). This concent ra t ion of o xeeat.c acid was
e x pec ted to produce a left shift in t he g l ucagon dos e -response
c urve, b ut i t d id no t . The half maxima l stimulation occurred
a t 3.5 ± 1. 3 vs . 2. 0 ± 0.1 nM (p > 0. 05 in absence or prese nce
of okada ic ac i d) as shown in Fig . 4.2. Simi lar r e s u l t s were
obta ine d when these e xperiments were repeated for the glucagon
s t imulation of glycoqenolysis . Hal f maxima l s timulatior.
occurred at 2.5 ± 0 .2 vs . 2 . 3 ± 1 .6 nM in the prese nc e of 0 .01
/.1 M okada ic acid , as shown in Fig . 4.3 . Hhen h epat oc y t es we re
p re i ncub a t ed wi t h a high c oncentration o f okada ic ac id ( 1 0~'M )
be f ore they were cha llenged with g l ucago n , a significant l e ft
s hift of the glucagon dose-response curve tor GCS a nd
glycogen olys i s o ccurred (Fig . 4. 4 an d F i g. 4 .5 ) . Half max i mal
stimulat ion o f GCS b y glucagon o c c urred at 3.2 ± 0.6 vs , 0 .2
± 0 . 1 oM i n t he presence o f 10" M okada ic acid, P < 0.05.
Pro t ein k i n a se A, or cAMP-dep endent protein kinase, is a
major k i nase res ponsible for ph osphorylating many cytosolic
pro t eins . In t he liver , glucagon i s kno wn to ece tv e t;e pro te in -
kinase A . The r efore, th e quest i on a rises to whether cAMP-
medi at ed phosp hory lat ion o f cytosolic prot e i n is r e s pons ib l e
fo r the activation of GCS, whic h i s a mitochondrial enz yme .
Sp -cAMPS, a ce l l -permeabl e ago ni s t f or prot ein ki n ase A, and
Rp -a-Br -cAMPS, a ce l l - pe rmeabl e a n tagon ist fo r prote in ki n ase
A, were used t o exa mine . the r equ La t Io n of GCS . Bot h of t hese
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Fiq . 4 .2 Effects o f s Ul:lmax i ma l o k a d a ic acid o n qrueeeen
s timu l a ti on o f GCS flux in i solat ed hepatocyte s
Okad a i c ac id (0 .01 pM) was pre incubated with the isolatod
hepatocytes for 20 minutes at J70C . This was followed by a 30
minute incubation per iod with q lucagon and i - vc q Lyc i ne . A
dose response curve for the glucagon stimulation o f GCS f l ux
without okadaic acid was done as a control . The basa l r a t e of
GCS fl ux is 1 .3 ± 0 .3 nmoles/ 30 mi ni mg dry wt , Resu l ts nrc
expressed as t he percentage of lhe unstimulated rate, w i thout
added okadaic acid . Results are means ± SO , n = 3 .
1 0 3
Fig. 4.2
EFFE CT OF 10 nM OKA['lAIC ACID ON T H E GLUCAGON S TIMULA TION

















0 / ·10 ·9 -8 -7 -6
LOG MOLAR [GLUCAGON]
-.- ALONE --- + 10 nM OKAO AIC ACID
104
Fig . 4.3 Eff e c t of subllaximal okadaic a cid o n t he gluca gon
s t i mul a t ioD o f g l yco genolys i s
A d os e-re s pon s e curve for g l ucago n was ca r ri e d out wi th ( _)
a nd wi thou t (e, pre inc ubat ing the hepatoc yt e s f or 20 a tnu n cs
wi t h 0 . 0 1 pH okadalc a c i d a t 37OC. Glyc ogenol ys i s was »eesu r ee
as nmoles of glucos e produced/ 30 mint mg dr y wt . Resul t s a re
expressed as percent age of the unst i llulated ba sa l ra t e wit hout
added okadai c acid and a re me ans of thre e se pa rate experiments
± s o . The basal r at e of glucose production is 2 0 2 ± 10 nmc Les
g lucose/ 30 minI mg d ry wt ,
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Fig. 4.3
EFFECT OF 10 nM OKA OAIC A CIDON THE GLUCAGON STIMULA T ION
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Fi q _ 4 .4 E ff ect of ma xim a l c o ncent r at i o n of ok al1a i c a c i d o n
qlucaqon- s timula tel1 GCS n ux in isolated hepat o cytes
I solated h epatocytes were pre incub<lted at ]7 "C f o r 20 minu t e s
with C. ) a nd wi thout Ce) 10-<1 H okada ic acid befor e a d di ng O. l
11IM l _I4C glycine and d ifferent concentrat ions o f qtuce q c n. 'rbc
"co, re leased is e xpres s ed a s a percentage o f th e b a s al rntc
without added ok a daic acid , The ba s a l r a t e fo r. GCS flux Is 1.7
± 0 .4 nmoles/ ) 0 minI mg dry vt • Resul ts are t he me a ns of
th ree separate e x perime nt s ± so,
10 7
F ig . 4.4
EFFECT OF MAXIMAL OO SE OF OKADAIC ACID ON THE
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F i q . -4.5 Effe ct o r: ma x i mal aka da ie a c i d o n the q l u e aqon
s timUl a t i on o r: qlycoqe no l ysis
Gl u cose p rodu c tion was determine d both in the p r e s e n c e (. ) and
absenc e ( e) of 10 "M okadaic acid . Th e basal rat e of g luc o s e
productio n i s 210 ± 21 n moles gluc o s e / ]0 min t mq dry wt .
Re s u l ts a re pres e n t e a <'IS the perc en t a g e or t he u nst te utoccd
r a t e and a r e mea ns t SO, n =] .
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Fig. 4.5
EFFECT OF MAXIMAL DOSE OF OKADAIC ACID ON THE GLUCAGON
STIMULATION OF GLYCOGENOLYSIS IN ISOLATED HEPATOC YTES
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co mpounds have a lready been used t o examine the regu lation of
glycogeno lysis a nd gluconeogenesi s i n i s olated hepatocytc s
(Ro t h e rme l er 031., 1983; 1984a ; Mes erve .>[ .11 . • 1986; Harks
an d Parke r - Bote lho , 1986) . Sp- cAMPS st i mula ted the fl u x
through GCS a nd glycoqenolysis wherea s Rp-8 -B r -cA MPS w..' s
wi t h o ut effect on either parallleter (F ig . 4 . 61 A co nt r o l
experimen t s howed that ne i t her Rp-8 -Br-cAMPS nor Sp- c AMPS hi' S
an e f f ec t o n the GCS flux in isola ted mitoc hondria (T,' b l e
4.2) . Thus t he effect of Sp -cAMPS i n i s ola t ed h ep at ocytcs i s
a t t r i but ed t o i ts ac t ivation of PK- A.
The ques t i on that was next cons idered is whethe r Rp -a-Br··
cAMPS would be a bl e to i nhibi t the Sp-cAHPS s timul a ted GCS
flu x in isolated hepa tocytes . Rp-8-Br -cAMPS did inhib it s p -
cAMPS s t imulation of both fl ux through GCS and qlycoqe n ol ysis.
A max imum inhibit ion was found at 10·t M Rp- 8-Br-cA MPS I Pi q .
•. 7 ) . Competition between the s e two cAMP a nalog ues wa s a lso
exami ned in experiments in which t he concentrat i on o f the
an tagonist was varied. Pre incubation o f isol ated hepa tocytcs
with Rp-B - Br-cAHPS (lO' s M) befor e they were c ha lle ng ed wi th
di f f erent co ncentra tions o f Sp-cAHPS c au sed a signif icant
i nh i b i t i on i n t h e Sp- Cl\MPS-s timulated GCS fluX" (Fig . 4.8 ) . l\
simila r i nhibit i on of Sp·cAMPs -s t i mu lated glycogenolysis wa s
ob s e rved at the s ame conc e nt r at i o n of Rp-8 - Br - cAMPS (Fig .
4 .9). The s e resu lts s h ow that Rp-8 - Br-cAMPS does a ntago nize
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Fig . 4 .6 Effect. of cI.MP a nalogues on the f lux t h rough GCS an d
g lycogenolysis i n isolated hepa tocytes
j s o La t ad hepatocytes pre incubated wi th va r y ing
concentrations o f Rp - 8 - Br - c AMPS tor 20 minutes a nd then were
incubated with a- ve glycine for a f urther 30 minutes. I n
e xperi ments wi th t h e st i mul a t ory Sp -cAMPS, t he hepatocyte s
were pre i nc u bate d alon e fo r 20 mi nute s a nd then I _ He gl y c ine
and Sp -cAMPS were a d ded a nd incubation continue d for a f u r ther
30 minutes. The basa l ra t e of GCS flu x was 1.7 ± 0 .3 nmoles!
)0 mi n! mg dry wt • and ha lf maximal s timulation of the flux
through GCS occur r ed a t 215 ± 69 .5 nM Sp-cAMPS. The basa l rate
a t gl uc ose product i on wa s 170 ± 34 nmo Leay 3 0 mi n! mg d r y vt •
Half max imal s timu l at i o n of g l ycogenolysis o c cu rred a t 18 1 ±
2 2 nM Sp-cAMPS. Results are prese nte d a s t he pe r centage of the




EFFECT OF Sp-cAMPS AND Rp-8-Br-cAMPS ON GLYCOGENOLYSIS
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Table 4 .2 Effects of Sp - c AMPS and Rp-8-Br -cAMPs on the f l ux
through GCS i n i s olated mi t oc hondr i a
F lux throuqh GCS
(fUllol e s HC02 re leased/ mg mitocho n drial
protein/ mi n)
Cont rol, _,0 0 .1 59 ± 0 . 02
Se-cAMPS, 10· 'M 0. 149 ± 0 .0 1
Rp- 8 -Br-cAMPS , l O· tM 0 . 16 3 ± . 02 3
Mi t oc h o nd r i a were i s o lat e d then preincuba tcd a lon e or with Rp-
8 -B::-- c AMPS f or 20 minutes . Then t hey were incu ba ted f or 30
mi nu t e s with S p - c AMPS and 0 . 3 mH r-vc glycine before the
reac tions we r e t e rm i na t e d wi t h 30 ' per chloric acid and I· CO,
was t rapped and c ounted . Results are given as nmoles HCO,J mq
mitochondria l protein/ lIIi n. and are means ± S O; n ", 3 .
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Fig. 4 . 7 Ef fec t s o f Rp-8 -B r - cAMPS on the Sp-cAMPS- stimulated
GCS f l ux and glyc o genolysis i n i solat e d hepatocytes
Isolated hepatocyt es were pre in cubated with di fferent
concentrations of Rp-8 -BR -cAMP5 f or 20 minutes be fore they
were i n c u ba ted wi th 10-· M Sp -cAMPS a nd O.J roM I _H e g lycine
for 30 minutes . The basa l rat e for GCS f l ux wa s 2 .0 ± o . 2
nmc t eey JO minI mg dry wt .and fo r g l uc os e p r o duc t i on , 120 ± 19
nmo l e s / 30 mi nI mg dry wt. Results were ex pressed as
percentage of the unstimulated rate a nd a re means r SD . e p c
0 .05 v s • control wit h no Rp- 8-Br-cMt PS , us i ng ANOVA.
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Fig. 4.7
EFFECT OF Rp-8 ·Br-cAMPS ON Sp-cAMPS ST IMULATION OF FLUX
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Fig. 4 . 8 Effect of Rp-8-Br~cAMPS on Sp-cAMPS s t i mu lat i o n o f
the flux through Ges
A dcae -eresp cnaa cu rve f o r the Sp - cAMPS s timul a t ion of the fl ul<:
through ccs was c a r ri ed out with (-) a nd without (e l 10 ·' M
Rp -S -Br-cAMPS . The ba sal ra te for CCS flux is 2 . 2 ± 0 . 5
nmoles/ 3 0 mini mg dry wt . Half ma x ima l stimulat ion occurred
a t (. ) 19S. 6 ± 100 and at (el 9 02 ± 133 nM Sp-ci\MPS. Resu lt s
are p ercentage of the unst i mulated rate and means o f three
separate experiments . ,., P < 0. 05 ve, contro l with n o Rp- 8 - Br -
cAMPS, by paired t - t e s t .
11 7
Fig. 4.8
EFFECT OF Rp-8-B,-<:AMPS ON Sp-<:AMPS STIMULATION OF
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Fiq. 4 . 9 Eft'eet ot Rp-8-Br-eAMPs on the Sp- e AMPS st. im ulat ion
o f q l y e oq e no l y a i s in i solated rat hepatocyte s
A do se-resp o nse cu r ve wa s carri e d ou t fo r the Sp-cAMPs
s timulation of g lycogenol ysis i n t he p resence a nd absence of
10 -s M Rp- S- Br -cl\MP S. The b asa l rate o f g lucose p r od u c t i o n wa s
159 ± 3 3 nmoles/ 3 0 mini mq dry wt. Ha l f ma)(imal stimulation
oc curred a t 22 0 ± 33 nM Sp -cAMPS vs • S0 4 ± 1 5 5 nM Sp -cAMPS in
t he p re s ence of 10 ·s M Rp -S -Br-cAMPS. The data a r e e xpressed
a s a pe r c e nt age of the u nstimU l a ted r ate and are mea ns ± SD .
* P <: 0 .05 VS. Sp - cAMPs wi th 10-s M Rp - S- Br - c AMPS : by p a i r e d
t - tes t .
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Fig. 4.9





























_ + Rp-8·Br ·cAMPS
The stimulat ion of GCS by sp-cAMPS . The effec t o f Rp- S-B r -
cAMPS on the glucagon-st imul ated GCS fl ux a nd glycogenolys is
was de t e rmined . Res ults presented i n Fig. 4 . 10 s how no e f fect
of Rp- cAMPS on the glu cagon s t i mul a t ed fl ux t hrough GCS
although it d id antagonize glucagon-stimu lated glycogenol ys i s
i n the same experiment. A dose-response c urve for t he g lu cagon
stimulation o f GCS f lux was carried ou t in the p resence a nd
absence of 10 ' $ M Rp- 8-Br-cAMPS (Fig . 4 .11) . No righ t s h if t of
the g l u cagon curve was ob s e rve d . ncvever , when g l ycoge nolys i s
was measured i n these experiments a significant r i ght sh ift i n
the glucagon dose response curve was found as s hown i n Fi g.
4. 1 2 .
Effect of c a l c ium - 1DOb i l iz i ng hormon e s on the GCS
The effects of vasopressin and a ng i o t e nsin lIon the fl ux
through GCS were examined since these hormones act through
i nc r e a s e s in i nt r ace l l u l a r Ca H c onc e nt ra tion a nd have no
effect on cAMP or protein kinase A in t he liver ( Ki r k and
He ms , 1974; Hems et e L, , 19 78 ) . Incubation of isolated rat
he p a t oc yt e s with 10 . 10 - 10 -' M vasopress in or a ngiotensin II
resulted i n stimulation of t he flux th r ough GCS and of
glycogenolysis as shown in Fig. 4 .13 a nd Fig . 4 . 14 .
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Fig. 4 .10 Ef f e c t of Rp-8-BrHcAMPS on the glucagon- stim ulated
fl ux t h.rough GCS and glycogenolysis in isolated hepato cytes
Isolated hepa tocytes we r-e pre i ncubated with different
concentrations of Rp-8-B r -cAMPS before t hey we re challenged
wi th 10 nM qlucagon . The basal r a t e of GCS flux is 2 .0 ± 0.2
nmolesl 30 mini mg dry wt. and basal r ate of glucose
production, 156 :!: 39 nmolesl 30 mini mg dry wt. ne s u t ec are
presented a s percentage of t he unstimulated. rate and a re means
of t hree experiments ± so . ... p c 0.05 vs • controls wi t h no Rp-
8 -B r -cAMPS; pa i red t -te!:t.
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Fig . 4.10
EFFECT OF Rp·8 ·Br·cAMPS ON THE GLUCAGON STIMULATION
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Fig. 4 .11 Effect o f Rp-8 -Br~cAMPs on glucaqon dose-respon se
c ur ve on the fl ux throuqh GCS in isola t e d hep atocytes
A glucagon close-response curve was done with ( -) and without
(el prei ncubation of the isolated hepatocytes with Rp -8-Br-
cAMPS. The basal rate of GCS flux i s 2 .3 ± 0.9 nmoles; 30 mi n;
mg dry wt • Half maximal stimulation ocurred at 2 .0 ± 0 .3 nM
vs . 2.7 ± 0.3 nM glucagon, respectivel y, in the absence and
presence of Rp-8 -Br-cAMPS. Results are mea ns ± SO, n "" 3 .
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Fig. 4.11
EFFECT OF Rp-8·Br-cAMPS ON GLUCAGON STIMULATION
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Fig . " .12 Effect o f Rp-8-B r - c Ahp S on g l u c a q o n - s t i mu] ,a l e d
g l ycogeno l y s is i n i sola t ed he p a t ocyt es
A dose-response c u rve fo r glucagon was ca r r i ed out with ( . )
a nd wi thout ( _) 10-5 M Rp- a -B r-cAMPS . The basa l rate of glucose
production is 205 ± 14 nmoles/ 30 mini mg dry wt.. Results a r e
means ± SO, n = 3. Ha lf maxima l st imulation is ( . ) 2 . 26 ± 0 .17
nM vs . ( . }5 .04 :t 0 .96 nM, p < 0 . 05 , pa i r e d t - test.
1 26
Fig.4.12
EFFECT OF Rp-8 ·Br-cAMPS ON GLUCAGON STIMULATION























Fig . 4 .13 Ef f e c t of v a s opr e s s i n on the flux through GCS and
qlycogenolysi s in isolated hepatoeytes
The basal rate of GCS flux is 2.2 ± 0.8 nmc l eay 30 minI rnq dry
ve • Th e oas.aj rate of glucose production is 139 ± 53 nmc l e ay
)0 minI mg dry wt. Results are presented as percentage of the
unstimulated rate of bo th GCS flux and glycogenolysis. Resul ts
are means o f three experiments ± SD .
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Fig. 4.13
EFFECT OF VASOPRESSIN ON THE FLUX THROUGH ccs



















Fig. -4.1 4 Effect of angi otensin lIon t h e flux t hr ou g h GCS and
g1ycogenolysi s in i solated hepa t o cy t es
Resu lts are expreeeee as percentage of t he unst imu lated rate .
T he basal rate for GCS flux is 1.8 ± 0 .2 nmo Leey 30 mini mg
dry ....t . The basal rate for glucose production is 101 ± 16
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___ GLYCO GENO LYSIS
Role of p r o t e i n k i nas e c i n t he r e g ul a t ion of Gce
The question of a possible r ole of protein kinase C in the
glucagon-stimulated flux t hrough GCS was examined . A dose-
r esponse curve for t he f lux through GCS and glycogenolysis was
done with phcj- bcL l2 - my ris t a t e 13- a ce t a t e ( PMA) and phorbol
l z- my r ist a t e 13 -acetate 4-0-methyl ether (PMA 4-0-rnethyl
ether) in isolated hepatocytes as s hown i n Fig . 4 . 15. PMA, a
tumour promoting phorbol es t e r , is a structural analogue of
d iacylglycerol t hat activates protein k inase C (Houslay,
1991 ). PM!>. 4-0-methy l e t her i nt e r ac t s poorly with protein
kinase C (Tronchere e t a1. , 1993) : therefore i t was used in
these exper iments as a control. No st imUlation was found with
either PMA or PMA 4~O-methyl ether .
We then examined if PMA wou ld have an e ffect on the
glucagon -stimulated GCS flux a nd glycogenolysis . Isolated
he patocytes were prodincubated with PMA or PMA 4-0-methyl ether
be fore they were challenged wi t h g lucagon . PMA had no effect
on s t imUlat i on of t he flux t hrough GCS (Fig. 4 .16) or
gl ycogenolysis (Fig . 4 . 17) by glucagon as i ndica t ed by the
magn itude of the maxima l stimulation a nd half maxima l
stimulat ion .
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F i g'. .. .15 Effec t of Pro on t he flux t h roug h GCS a nd
q lycog e nolysis i n isohted hepatocyt e s
I s o lated hepa t ocy t e s were p r e i ncuba t ed f or 20 minu t e s wit h PMA
b e f ore t he r eaction was in i t i a t ed by add it i on of 0.] 11M 1 _" C
glycine . Cont rol incubations we re carr i ed ou t with PHA me t hyl
ether . The basal rate of GC S flux i9 1 . 5 :!:: 0 .2 nmoles/ ) 0 minI
mg dry wt . The basa l rate of g lucose p roducti on is 195 ± 35
omolesl 30 mi nI mg dry ve • Resul ts are means o f t hree s ep ara te
e x per i me nt s ± s o .
l J J
Fig.4.15
EFFECT OF PMA ON TH E FL UX TH ROUG H GCS AND
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Fig. 4.16 Ef f ect of PMA on the g l uc agon s timulatio n of GCS
fl u x i n i solate"" he p a t o cy t e9
Is ol ated he patocyte s ve r e p r e i nc u bat ed in the presence or
abse nce a f PMA and PMA met h yl e t h er, a f t e r whic h t he y were
Incubated wi t h v arying concentrat ions of q l ur-aqcn and 0 .3 mM
i - vc glyc ine. T h e basal rate i s 1 .J ± 0 .6 nmo les/ 3 0 lIltn; mg
dry wt. Res ul t s a r e presen t e d as percent ag e o f the
unstimulated ra te a n d are means ± SO, n '" 3 . Hal f max i ma l
stimul atio ns a r e (.) 2. 2 ± 0 . 4 (0) 2 .6 ± 0.2 nM (-)2 . 1 ± 0. 26
nM, p > 0 .05, paired t - t est .
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Fig . 4.16
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Fig . 4 .17 Ef f ect o f PMA on. g l uo aqon- s t i mulated qlyco qenoly9i s
in i solated rat hepatocytes
The isolated hepatocytes we r e p re incubated in the presenc e or
a bsenc e of PMA or PMA met hyl ether . Resul ts a re percentag e of
t he unst imu lated rate a nd are mea ns ± SO o f three eepe r et.e
e xperiment s. The ba s a l rat e o f gluc ose produ c t i on is 173 ± 5 0
nmoles/ 30 minI mg dry wt . Half maximal conce nt rations a r e (e )
3 .5 ± 0.4 nM (.) 3 .6 ± 0 . 6 nM ( 0) 3 .3 ± 0 . 2 nM, p > 0 .05 ,
p a ired t-tes t .
13 7
Fig. 4.17
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Discus sion
Although the regulation of the CCS e n zyme system b y
hormones has been es t ablished, t h e mechanism by which t h o
signal i s transmitted from t he glucagon r ecep e or t h rough t he
cy top lasm i nto mitochondria is not know n.
Phosph o rylat ion/ dephosphorylat ion e ve nt s p l .,y i mpo t"t a n t
r ole s in metab o lic regul a tion, pe r tiLcu j a r Ly in glucagon
ac tion . Therefore , t he possibili ty of t he invo lvement o f
phosphorylated p r oteins in t he r egulation of GCS was e xa mi n e d
by using t he cytosolic prote in phosphatase inh i bitor cknd a ic
acid . Okadaic a c i d ' s specific effect is to inh i bi t "P I and
PP2 A i n t h e cytosol lead i ng to i nc rease in the l e v e l of
phosphorylated proteins (Cohen and Cohen, 1989) . Resu l t s shown
i n Fig . 4 . 1 a nd Fig . 4 . 2 s u ggest tha t t nc r ee ee i n cy toso lic
p r o t ein p hospho ryl ation , produced by o k ada i c a cid, causes a
sign ifican t increa s e in the flux t hr o ugh GCS and
g lyc ogenolys i s . Res ul ts from table 4.1 confirm tha t okad a i c
acid had no d i rect effect o n GCS flux i n isola ted
mitocho nd ria . In iso l a ted hep a t ocyte s , Ha ys t ead e t: ell . , (19B9 )
r eported a 3 fold increase in the level of cytop l as mic
phosp ho r y l ated p r oteins i n respose to okadaic ac id with no
increase in t h e mi c r os oma l f ra c tion. Howeve r , in t heir
e xpe r i men ts, the mit o chondria l f raction was no t examined t o
de t e c t any i ncre a se i n t he l e ve l of phosphory l a ted p rotei n.
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The finding that ok a d e Lc a cid mimics hormonal actions o n
the flux th r ough GCS r aised the qu e st ion of possible
i nvo l vement o f phophorylation/dephosphorylation of c y t op l a s mi c
prote ins i n t he h o rmonal signa ll ing t o the mitoch ondrial
e nz yme GCS . The data in Fig. 4 . 2 show t h a t a subm aximal
c o nc e nt ration of c ka de Ic acid did not produce a left s hi f t in
the glucagon curve. Oka da i c a cid at a concentration of l O·'M
WdS able to produce a signif i cant left shift o f t he glucagon
dose - response c ur ve (Fi g. 4 .4) . This result s uggests that
c y t os o l tc protein ph osphorylationmay be an important e lement
in t he glucago n stimulation of t he f lux th rough GCS.
Protein kinase A, or cAMP-dependent p rotein kinase, i s
responsible f or the phosphorylat ion o f ma ny c ytos Ol i c
p roteins . I n add ition , Protein k i n a s e A is imp licated i n
glucago n action . Therefore , it is possible that c AMP- i nd u c e d
phosphorylation may also be i nv olve d in the regulation of GCS.
Sp -cAMPS a nd Rp-8-Br-cAMPS, the cAMP analogues, we re used to
examine t h i s hypothes is . Sp-cAMPS significantly stimUlated the
GCS flux while Rp-8-Br -cAMPS had no effect o n t he GCS flux or
on the basal rate of HCOt product ion . Furt hermo.•: e , the Sp -
c AMPS -stimulated fl ux through GCS i s i nh i bit e d by t he protein
kinase antagonist , Rp-8-Br- cAMPS which shows that stimulat i on
of the cytosol i e cAMP- d ep endent protein k inase can stimulate
the flux t hrough GCS.
The poss ibility of i nvo l ve me n t of cAMP-dependent
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phosphorylation in t he glucagon effect on GCS was ex a mi ne d . A
r ight s hi f t i n the glucagon dose-response curve caused by Rp-
a-Br -cAl ~ 3 wo u Ld s trongl y support the idea t hat glucagon is
s timulat ing the f lux t h r o ugh GCS via cAMP-dependent i ncreases
in ph os ph o r ylat i o n of cytoplasmic protei ns . Our r e s ul t s show
that there is no signiticant change in t he gl u cago n r espo ns e
curve . Howeve r , Rp -S -Br-cAMPS did antagonize the q Lucaqon-.
stimUlate d g l yc ogeno lys i s which is consis tent with results of
Rot hermel e r a1., (1984a).
A possible e xp lanation for t he absence of a n i nh i b i t ory
e ffect of Rp-8 -Br-cAM PS on glucagon-stimulated flux t h r o ugh
GCS would be t hat gl uc a go n s t imu lation lead s to increase i n
both cAMP an d Ca H (Wake lam et a 1 . , 1986; Jeli ne k .'It .I I .•
199 3 ) , i n the l i ve r . Rp-8 - Br -cl\MPS may inhibit the increase in
c AMP conce ntr at i o n bu t would not affec t the increase in
calc ium co nc entr ation which may be a n important element i n t h e
g lucago n r e gulat i o n o f GCS. The ob s ervation t ha t
phosphor y l a tion o f some glucago n targets can be stimu l a ted by
agents tha t i ncreas e i ntracel lula r ce" concentration (Ga rrison
a nd Wa g ner, 198 2 ; Garr i s on at: a1., 198 4) raised t he
pos sibility t ha t ca2+/calmodulin-sensitive prote in k ineees ma y
a lso p l aya role i n t he r esponse o f he pa t o cy t e s to glucago n .
The role o f int r acellular c e" i n t he regulation of GCS was
ex ami ned wi th the c a l c i um mob ilizi ng hormo ne s , vasopressi n and
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angiotensin II. They both stimulated the fl u x t h r ough GCS and
glycogenolysis . Th is i s c onsis t e nt wi th the results presented
by Hems ec 031. , (1978) a nd Jois e c 031., (199 0a ) . Hems e c 031 .,
(1 978) r eported rap id st imulation of glycogenolysis by (10 pM-
1 0 nM) vasopressin and (1 nM- 0 . 1 ~M) angiotens in I I i n
hepatocyte s uspens i ons . Jois et 031., (1990a ) reported
s t i mulat i on of the f lux"· '; h GCS in isolated r a t l i ver
perfused with 1 00 nM v asopr e s s i n .
The question as t o whether protein ki nase C i s involved in
the regulation o f the GCS e n zyme system was examined using
ph or bo l esters . Results in f ig . 4 .19 show no effect of PHA or
PMA 4-0-methyl ether on t he GCS or g lycogenolysis, whi ch
s uggests no r ole for protein kinase C on the flux through GCS
or glycogenolysis. Our results are in agreement with those of
Corvera and ce r cia -aatna, (1984) who showed that (lO ·u-1o·'M)
PMA wa s unable to stimUlate glycogenolysis i n i s o l a t ed rat
hepatocytes. In addition, there was no effect of PHA on the
g lucagon stimulation of t he flux through GCS
glycogeno lysis. This is consistent wi th Corvera and Garcia-
sainz, ( 198 4) who showed that the stimulation of
g lycogenolysis by g lucagon was unaffected b y PMA in isolated
ra t he pa t oc yt e s . Although 0 . 1 - 1 ~M PMA has been reported to
decrease t he accumulation of cAMP induced by glucagon, it d id
no t affect t he glucagon -stimulated ureogenesis (Garcia-sa inz
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e e a1 ., 1985 ). Dissociation between the cAMP conce nt ra t Ions
and the metabolic effects induced by glucagon is evidenced i n
t he presence of phorbol e s ters . I n the perfused rat liver,
infusion o f PMA f o r 20 minutes prior to i n fu s i o n o f g l uca gon
d i d not alter g l ucagon-stimula ted g l ycogeno lysis as meas u re d
by the increase in g l uc os e output a nd de c r ease in t ac t at.o
output ( Pus c he l e c ai., 1993). ThE!refore , we s ugge s t t hat
p r otein ki na s e C d oes no t play a role in the re gulation of
GCS. Howeve r , we s hou l d be awa re t ha t u e i nq ph or bo l esters ,
which are s t ructu r a l an alogues of diacylglycerol, has some
p r ob lems . The fi rst problem i s t ha t phorbol esters acn I e v c a
p r olonged a c t i v ation o f prote i n ki nse C and may cause its
down- r eg ulation (Nish izu ka , 1988 ) . The second p r ob l e m is that
diacy lglyc erol pr od uc ed i n t he c ell may ac t ivate protein
kinase C i s o forms s e l ectively, de pen d ing upon its f a t t y acid
comp osit i on a nd that s uch a variety o f activi ty may be
d iffe r e nt from tha t ach ieved by phorbol es te rs .
Unansw ered questions
The occ up ation of the gluc agon r eceptor by gluc ag on e xerts
t wo main e f f ects . The f i r s t effec t is t hat it stimu la t es
a d e ny l a t e c ycl a s e with the co ns e quent r ise in [c AMP]
( He yworth and Hou s lay , 1983 ) a nd the inc r ease i n t he
c oncentrat i on o f phosphory l a t ed prote i ns . The second e f fec t i s
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a n i nc r e a s e in f ree (eah ) , as ini tiated by the s t i mul a tion of
p hosphoinositol t urnov e r (Wa ke l a m er <il . , 1986; Mine e z a l .,
1 988) . These events occu r vi a dist i nct G p roteins.
Glucagon was found t o s t i mu l a te the flux t h r ough GCS.
Howeve r , i t is not known exactly whi ch signalling pathwa y is
r e s pons ible tor t he activa tion o f t h i s mi t oc ho nd r i a l e nzyme,
o r how t he honnona l signa l is t ransmitt ed t o the mi tochond ria
( Fig . 4 .18 ) . The r e f ore we exam i ned the e ffect o f va r ious
agents tha t s pecifica lly stimulate or inh ib i t c e rta i n parts of
the s i g nalling p athways . Ou r r e su l t s de mons trate the
i nvolve me nt u f protein ph o s phoryla t i on , cAMP , a nd
i n t ra ce l l u l ar c a l c ium conc e nt r a t ion i n t h e s timUl a t i on o f t he
GCS by norncn e e s uch a s g l uc ag on .
However . a nUlllber o f un a nswered qu e s t i ons s til l ne ed t o be
i nves t i g a ted . The identity of phosphorylat ed pr o t eins an d
their location wi t hi n t he h e pa t ocy t e s is no t known . The
ques tion of how t he i ncreas e i n cyt os o l i c prot e i n
phosphoryl ati on ca n affect the GCS whlch i s l ocat ed inside the
mitochondri a r e mai n s unanswered and s till ne eds t o be
exa mi ne d .
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1 . Glicentin a nd oxyntornodulin stimulate t h e fl ux th roug h GCS
i n isolated rat h e patocyte s .
2 . ru t c e ne In and oxytomod u l i n e xe r t their effects in isolated
rat hep atocytes t hro ugh i nteract ion wi t h g lucagon rec eptors.
a . GLP- l a nd mln l gluc agon have no ef fect on the glycine
c l e a v age s y s t em . GLP- l a nd minigluc ag on a re ne ithe r agon ists
nor antagonists f or gluc agon i n i s o l a t e d hepa tocytes .
4 . Okad aic a cid , the cell -permeable c yt os olic protei n
phosphat ase i nhib i t o r, stimu lates the fl ux t hrough GCS .
5 . Sp-cAMPS , a protein kinase A agonist, s timulates t he f l ux
through GCS i n isolated hepatocytes . Thi s stimulation c a n be
inhibited by the protein kinase A antag onist Rp - a - Br -cAMPS .
Thus i ncrease in cytoso lic protein phospho r y lation levels,
pr ob a b l y through a cAMP-dependent protein kinase , c a n c a us e a n
increase in the flux through GCS .
6 . The glucagon-stimulated flux through GCS i s no t i nh ibi t ed
by t h e prote i n kinase A antagonist , Rp-8-Br-cAMPS a lthough it
i s able to inhibit the activa tion of g l ycoge no l ysis, a
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cytoplasmic p r ocess . This suggests t ha t t he signalling
mecha nism involved in transmitti ng t he g lucagon signal into
mitochond r ia is more comp l e x and may involve many elements.
7 . The ca lcium-mobilizing hormones, va s op r e s s i n an d
angiotensin I I, s t imu l ate t he fl ux t hrough GCS. However, i n
isolated hepatocytes they did not po t en t ia t e t he glucagon
stimulation o f GCS flux at the concentrations tested .
8 . Phorbol e s t e r s do not i ncrease t he fl ux t hrough GCS
the i r own, nor do t hey po tentiate t he effect of a su bmaximal
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